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Chapter 1- Introduction
Epigenetic reprogramming of the genome
A major goal of current research is focused on understanding the mechanisms that
govern nuclear reprogramming, which is defined as the changes in gene expression
patterns that expand the developmental potential of a fully differentiated cell to a
totipotent state. Nuclear de-differentiation through transplantation of the nucleus into an
enucleated oocyte is one experimental approach to reprogram somatic cells. Somatic cell
nuclear transfer (SCNT) is ultimately aimed at generating uncommitted stem and
progenitor cells that may be useful for cell replacement therapies. The success of
reprogramming fully differentiated cells using SCNT has demonstrated that no genetic
information is lost during development, with the exception of antigen receptor genes in
lymphocytes, and that nuclear totipotency is retained for all cell types thus far studied.
The low but reproducible success of SCNT in reprogramming a range of differentiated
cells back to totipotency suggested that epigenetic mechanisms of gene regulation and
differentiation are responsible for keeping cells in their state of differentiation. Epigenetic
refers to mitotically stable modifications of DNA or chromatin that do not alter the
primary nucleotide sequence. Epigenetic reprogramming is intended to reset these
modifications from a fully differentiated to a less differentiated state, ideally to the
totipotent embryonic state that allows differentiation into all lineages.
The goal of the studies described here was to establish a set of methods aimed at
ultimately enhancing the efficiency of epigenetic reprogramming. To this end, three
experimental avenues were accomplished. The initial study developed an approach to
allow conditional regulation of epigenetic modifiers using RNA interference. DNA
methylation is probably the best studied epigenetic modification known to regulate the
expression of key embryonic “pluripotency genes” (Boiani et al., 2002; Bortvin et al.,
2003) such as Oct-4. Consistent with the inverse correlation between DNA methylation
and gene expression, DNA hypomethylation of the genome significantly increases the
reprogramming efficiency after nuclear transfer (Blelloch et al., submitted). However as
discussed below, global hypomethylation also increases the risk of genomic instability
and tumor formation. To avoid adverse effects of DNA hypomethylation, we have
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developed a Cre-lox based system for conditional gene suppression by RNA interference.
It allows in a simple manner to study the effects of transiently down regulating an
essential gene, such as Dnmt1, in order to increase epigenetic reprogramming. By
subsequently reversing the knockdown and thereby restoring endogenous gene
expression many deleterious effects of longer term suppression can be avoided.
The second application of our conditional gene knockdown approach using RNA
interference was aimed at testing the notion that development of an embryo derived by
SCNT might be restricted by temporarily inactivating a gene essential for development,
yet the same embryo might be fully competent for extracting embryonic stem cell lines
useful for therapeutic purposes. Due to incomplete epigenetic reprogramming many
cloned embryos fail to express (reactivate) one or more of a set of “pluripotency genes”,
with Oct-4 being one of the best studied members of this class (Boiani et al., 2002;
Bortvin et al., 2003). However, many of the abnormalities observed in cloned animals
involve also deregulation of gene expression in the placenta (Humpherys et al., 2002). It
appears that many placenta-specific genes are also not reactivated after nuclear transfer
(Hall et al., 2005). Cdx2 is an essential transcription factor for trophectoderm
differentiation and might be involved in some of the cloning phenotypes. Owing to its
crucial role it was also an ideal candidate to test a concept called altered nuclear transfer
(ANT) that has been proposed as a modification of the current NT technology. We have
demonstrated the feasibility of the ANT technique, which now provides a scientific basis
for the discussion surrounding alternative ways of deriving stem cells. Our findings
confirmed previous results gained through deletion of Cdx2 by gene targeting (Strumpf et
al., 2005). The phenotype of our knockdown was indistinguishable from the published
knockout phenotype. Importantly, the generation of conditional Cdx2 shRNA expressing
ES cells takes only a few weeks compared to at least two months for a knockout of both
alleles by gene targeting (see discussion). Moreover, loss of Cdx2 is early embryonic
lethal (blastocysts fail to implant) and no conditional knockout has been reported to date.
Conditional Cdx2 ES cells will therefore be a useful tool to further investigate the role of
Cdx2 in development.
Finally, another approach in studying epigenetic reprogramming is to determine
the epigenetic differences between different cellular states, and to further elucidate what
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defines the nature of “stemness” within a stem cell. DNA methylation is probably the
best studied epigenetic modification that determines patterns of gene expression within a
cell. In order to better define the epigenome of different cell types, we have developed an
approach for large-scale high resolution DNA methylation analysis. The results presented
in this work provide new tools and insights for the study of epigenetic reprogramming.
Before describing the main findings of each of these three projects, I will review in more
detail the background concepts for the major topics covered by my research.
RNA interference
Overview
In the past decade, small RNAs have emerged as central regulators of gene
expression from worms to humans.
Two studies published in 1993 were the first to show that small non-coding RNAs
were involved in gene regulation (Lee et al., 1993; Wightman et al., 1993). Lee and
colleagues discovered that lin-4, a gene involved in the timing of C. elegans larval
development, did not encode a protein, but rather a 22 nucleotide-long RNA that was
predicted to arise from a longer precursor. This group and Wightman et al. then
discovered that the lin-4 RNA molecule was complimentary to multiple sites in the 3’
UTR of another gene, lin-14. Both groups suggested that the binding of the small lin-4
RNA to the lin-14 UTR might repress the translation of lin-14, which is required for the
transition from cell divisions of the first larval stage to those of the second (reviewed in
(Bartel, 2004)). It took several years before additional small regulatory RNAs were
discovered (Bartel, 2004). Because the first small RNAs to be identified were involved in
timing developmental transitions, they were referred to as small temporal RNAs
(stRNAs). Later cloning efforts revealed that this new class of RNAs was much broader
than originally thought, with many of them expressed in a tissue-specific rather than
timing-dependent manner. As a result, stRNAs were renamed microRNAs (miRNAs)
(Bartel, 2004).
A few years later, studies in C. elegans showed that double-stranded (ds) RNA
was a substantially more potent and long-lasting inhibitor of gene expression than single-
stranded (ss), or antisense, RNA (Fire et al., 1998). Thus, although the endogenous small
RNAs (miRNAs) had already been discovered, their true gene-inhibiting potential was
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not appreciated until the study by Fire and colleagues emerged and, ultimately, paved the
way for the RNA interference (RNAi) revolution (Fire et al., 1998).
RNAi is now appreciated as one of the most powerful ways to silence gene
expression, and this technique has rapidly transformed gene function studies across
phyla. RNAi operates through an evolutionarily conserved pathway that is initiated by
dsRNA (reviewed in (Dykxhoorn et al., 2003; McManus and Sharp, 2002)). In
eukaryotes such as plants and worms, long dsRNA (e.g. 1000 bp) molecules that are
introduced into cells are processed into ~21 nt siRNAs by the dsRNA endoribonuclease
Dicer (Bernstein et al., 2001). These siRNAs can then associate with a complex known as
the RNAi-induced silencing complex (RISC) and direct the destruction of mRNA
complementary to one strand of the siRNA. Recent studies have shown that the choice of
RNA strand that is incorporated into the RISC is non-random and thus has important
consequences for the design of siRNAs (Schwarz et al., 2003). siRNA design will be
discussed in detail below.
Although the Dicer pathway is highly conserved, the introduction of long dsRNA
(>30 bp) into mammalian cells results in the activation of antiviral signaling pathways,
leading to nonspecific inhibition of translation and cytotoxic responses (Stark et al.,
1998). One way to circumvent this problem is through the use of synthetic siRNAs that
transiently down-modulate target genes without triggering cell death (Elbashir et al.,
2001a). The subsequent discovery that plasmid-encoded interfering RNAs could
substitute for synthetic siRNAs permitted the stable silencing of gene expression
(reviewed in (Mittal, 2004)). In these systems, an RNA polymerase III promoter is used
to transcribe a short, inverted stretch of DNA, resulting in the production of a short
hairpin RNA (shRNA) that is then processed by Dicer to generate an siRNA. These
vectors have been widely used to inhibit gene expression in mammalian cell systems.
More recently, several groups have reported the use of similar expression constructs for
the generation of RNAi-expressing transgenic mice (Carmell et al., 2003; Kunath et al.,
2003; Rubinson et al., 2003), which, in some cases, recapitulate the phenotype of mice
genetically deficient for the gene in question (Kunath et al., 2003; Rubinson et al., 2003).
RNAi: siRNAs, shRNAs and miRNAs
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As shown in Figure 1, the different groups of small RNAs enter presumably the
same RNAi pathway. Long dsRNA, shRNAs and miRNA precursor are all  processed by
Dicer into small RNA species. Alternatively, synthetically derived 21-nt long dsRNAs
can feed directly into the endogenous RNAi processing pathway. Long dsRNAs,
although effective in C. elegans, cannot be used in mammalian cells (see above) and will
therefore not be discussed in more detail.
MicroRNAs are endogenous, small non-coding RNAs that are involved in gene
regulation (Bartel, 2004). Most studies suggest that endogenous microRNAs are
transcribed by RNA polymerase II as longer primary nuclear transcripts, and are then
processed into smaller, ~70-nt long pre-miRNAs by the RNAse III endonuclease, Drosha.
These pre-miRNAs are then exported to the cytoplasm. In contrast, shRNAs are typically
transcribed by RNA polymerase III using the U6 or H1 promoter. Functional siRNAs,
shRNAs and miRNAs all share a preference for A/U basepairs at the 5’ terminus of the
antisense (AS) strand of the target gene, indicating a strand bias in stability and also the
existence of a joint, indistinguishable pathway as illustrated in Figure 1.
Figure 1: RNA interference. The RNAse III endonuclease, Dicer, generates small RNAs from
long dsRNA, shRNAs and pre-miRNAs that become incorporated into the RISC. Depending
on the target identity this can lead to translational repression or mRNA degradation.
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In general, it is assumed that miRNAs pair imperfectly to the target sequences and
that they work by repressing rather than degrading the target gene. However, recent work
in C. elegans has demonstrated that this might not be true for all miRNAs (Bagga et al.,
2005). In that study, the authors show that let-7 degrades its target gene lin-41, despite
only partial base-pairing. The targets of the lin-4 miRNA, lin-14 and lin-28, are degraded
in a similar fashion (Bagga et al., 2005). Doench and colleagues have shown that, like
miRNAs, siRNAs can repress the translation of target mRNAs with only partial
complementary binding sites (Doench et al., 2003).
Following cleavage and nucleo-cytoplasmic export, the miRNA pathway appears
to be indistinguishable from the siRNA pathway. Long dsRNAs, plasmid-based shRNAs,
synthetic siRNAs and miRNAs are likely processed through the same endogenous,
evolutionary conserved pathway. Although miRNAs and siRNA are processed similarly
and are composition-wise indistinguishable, their origin and evolution are different
(reviewed in (Bartel, 2004)). Post-transcriptional repression, cleavage or translational
repression of mRNA appears to depend on identity of the target sequence rather than the
origin of the small RNA (miRNA or siRNA). Notably, when a miRNA cleaves its target,
the cleavage occurs at the same position as that cleaved by a siRNA, i.e., between the
nucleotides complementary to residues 10 and 11 of the si/miRNA (Bartel, 2004;
Elbashir et al., 2001b).
In addition to regulating gene expression at the posttranscriptional level, small
RNAs can also suppress gene expression at the genomic level. RNA-directed DNA
methylation is well established in plants (Matzke and Birchler, 2005), and has recently
been shown to occur in human cells as well (Kawasaki and Taira, 2004). However, the
latter report still awaits confirmation in independent studies.
The human genome is estimated to harbor approximately 200-255 miRNA genes.
C. elegans and Drosophila have approximately 103-120 and 96-124 miRNA genes,
respectively (Bartel, 2004). Most of the miRNAs that have been cloned are conserved in
closely related species, such as mouse and human. Even more striking, more than a third
of C. elegans miRNAs have a homolog in humans (Bartel, 2004). Recently identified
miRNAs include those that are involved in cell proliferation, cell death, fat metabolism
(flies), neuronal patterning (nematodes), differentiation of hematopoietic cells (mice), and
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control of leaf and flower development (plants) (reviewed in (Bartel, 2004)). More than
200 microRNAs have been described in humans, although the function of a majority of
them is unknown. The 5’ region of microRNAs -- in particular the seven nucleotides at
position 2-8 -- are essential for siRNA/miRNA function. These “core elements” or “seed”
sequences determine the specificity of the siRNA/microRNA. Not surprisingly, these
sequences are highly conserved and have thus been used to predict target mRNAs using
comparative genetics and computational analysis (Lewis et al., 2003).
Two recent reports implicated miRNAs in tumorigenesis. The first found that a
frequent chromosomal amplification (13q31-q32) contains a miRNA cluster that might be
involved in the underlying malignancy (Ota et al., 2004). He et al. over expressed this
miRNA cluster (miR17-92) in a mouse B-cell lymphoma model and showed that it
accelerated tumor development when combined with c-myc, suggesting that miRNAs can
act as oncogenes (He et al., 2005).
Design of siRNAs and shRNAs
When long dsRNA is used for RNAi, target selection is not required, as an array
of siRNAs is produced from the longer dsRNA. One or more of these siRNAs will have
the right sequence and effectively knock down the mRNA of interest. However, in
mammalian cells, with the exception of early embryos, dsRNA cannot be used,
necessitating the design of a single synthetic siRNA or shRNA that can efficiently
suppress the target mRNA.
Elbashir et al. were the first to demonstrate that synthetic 21-nt duplex RNAs can
specifically silence target mRNAs without triggering an interferon response in
mammalian cells (Elbashir et al., 2001a). When siRNAs were generated from long
dsRNAs by Dicer, a large number of distinct 21-nt long RNAs are produced. Although
this approach is effective for gene silencing, it is impossible to determine which of the
21mers is producing the knockdown. The first insights regarding the mechanism of
RNAi-mediated cleavage were provided by the same group (Elbashir et al., 2001b). By
cloning the Dicer cleavage products of long dsRNAs, they found that nearly half were
21-nt and about a third 22-nt in length (Elbashir et al., 2001b). Based on this initial
finding, a number of general design rules have been suggested (Elbashir et al., 2002). The
principle design consisted of a 19-nt core sequence with a GC content of 30-70% --
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which appeared to lend internal stability -- with 2-nt overhangs on either end: AA at the
5’ and TT at the 3’ terminus. Even with these rules, the design of siRNAs was still
largely based on trial and error. This changed when Schwarz et al. showed that the
absolute and relative stability at the 5’ ends of the siRNA duplex determined which
strand would be incorporated into the RISC complex. (Schwarz et al., 2003). This
asymmetric incorporation into RISC has important consequences for the design, as the
antisense strand of the siRNA can direct cleavage of only the sense strand mRNA target.
The next step towards improving the rational design of siRNAs came from a
systematic analysis of the efficiency of 180 siRNAs that targeted two genes at every other
base (Reynolds et al., 2004). An analysis of the functional and non-functional siRNAs
suggested a new set of design rules, which included low G/C content, a bias towards low
internal stability at the sense strand 3’-terminus, a lack of inverted repeats, and sense
strand base preferences at certain positions. Each parameter was assigned a numeric score
(-1, 0, or +1) with a maximum total score of 10. A score of 6 or higher translated to a
five-fold higher probability of achieving 80% inhibition when compared to a random
sequence (Boese et al., 2005; Reynolds et al., 2004). In general, applying these rules has
significantly improved the average efficiency of target degradation. It should be noted
that several of the shRNAs used in this work, such as Cdx2, have been designed
according to these rules (see Methods and Materials). Notably, most effective shRNAs
that were selected by trial and error followed these rules and had scores of 6 or higher
based on the criteria listed. Importantly, although these rules were established using
siRNAs, they appear to work equally well for the design of shRNAs.
In our hands, the rate of generating potent knockdowns using these rules ranges
from 25-50% of the shRNAs designed. Despite this relatively high success rate, it is
advisable to test the knockdown efficiency of shRNAs in reporter assays before
proceeding to the actual experiment. There are many different ways to test for functional
knockdown (reviewed in (Sandy et al., 2005)); one simple assay used for the selection of
Cdx2 shRNAs is described in Figure 12 (Chapter 3).
Finally, it is worth mentioning that the secondary structure of the target mRNA
does not appear to play a significant role in determining the efficiency. This conclusion
was based on the sorting of siRNA functionality classes to a predicted mRNA target site
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accessibility value (Boese et al., 2005). This was further supported by the observation
that shifting a siRNA by only two base pairs along the mRNA can dramatically alter the
silencing efficiency (Reynolds et al., 2004).
RNAi and its applications
Owing to the ease of synthesizing siRNAs and creating shRNA vectors, RNAi is
an attractive tool for large-scale library screens that ultimately allows one to target every
gene in the organism of interest (Hannon and Rossi, 2004). Particularly exciting are
recent array-formatted, retrovirus-based, barcoded shRNA expression libraries that target
human and murine genes (Berns et al., 2004; Paddison et al., 2004). To further enhance
the potency of the knockdowns, the next generation of shRNA libraries has applied
improved shRNA design and then embedded the shRNA sequence in microRNA
sequences to mimic endogenous small RNAs (Silva et al., 2005).
The potency and specificity of RNAi also make this technique attractive for
therapeutic purposes. Potential applications include the down-regulation of oncogenes or
growth factors for the treatment of cancer (Hannon and Rossi, 2004). Due to the
importance of particular base-pairings for effective interference, one could envision
designing shRNAs that specifically target a mutant, disease-causing allele. The use of
single nucleotide polymorphisms (SNPs) to achieve such specificity has been
demonstrated in preliminary studies (Miller et al., 2003). ShRNAs have also been tested
for the treatment of viral infections, in particular HIV. The main problem with this
strategy is that the high mutation rate of HIV makes it difficult to target the viral RNA.
However, targeting cellular HIV co-receptors, such as the CCR5 receptor, have shown
promising results in human lymphocytes (reviewed in (Hannon and Rossi, 2004)).
Another attractive target for RNAi treatment is viral hepatitis, as there is no vaccine or
treatment for hepatitis C virus (HCV), and hepatitis B virus (HBV) can be prevented only
by vaccination . McCaffrey and colleagues demonstrated that they could achieve a
significant (99%) knockdown of the HBV core-antigen in liver hepatocytes by shRNA
(McCaffrey et al., 2003). In a different study Song et al. used hydrodynamic injection of
siRNAs into mice to silence the Fas-receptor. This led to inhibition of Fas-mediated
apoptosis in the liver and the prevention of fulminant hepatitis, which would result in the
mouse’s death (Song et al., 2003).
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These reports, among many others, highlight the potential for the use of RNAi in
disease therapy. However, many issues still need to be resolved, including the delivery
and specificity of siRNAs. In particular, the potential for off-target effects requires
further investigation (Jackson et al., 2003). In general, to reduce the chance of off-target
effects BLASTn searches should be performed for all si/shRNAs. When performing these
searches, the word size, which determines the search window for identity, should be set
to the lowest possible value (7 for BLASTn) and the significance value (expect value; E
value) should be set relatively high (e.g.,>1000) to better suit short sequences.
Nuclear transfer
The early days of nuclear transplantation
It is fascinating to consider that a single cell, the zygote, gives rise to an organism
with hundreds of different cell types represented by trillions of individual cells. It is even
more striking that, with few exceptions, the genetic content of each differentiated cell
remains identical to that of the original zygote. These cells therefore retain all the genetic
information necessary to generate an entire organism. While this idea of “nuclear
totipotency” or “nuclear equivalence” is now well established, it was not clear a few
decades ago whether or not cells lose genetic information during the process of
differentiation (reviewed in (Hochedlinger and Jaenisch, 2002b)).
In 1952, Briggs and King attempted to address this question by pioneering a novel
technique termed nuclear transplantation (Briggs and King, 1952) (Fig. 2). Their
approach was to transplant the nucleus of a differentiated cell into an enucleated oocyte
as a means of assessing the nuclear potency of the differentiated cell. Using nuclei from
frog blastomeres, Briggs and King demonstrated that the nuclei could be reprogrammed
to a zygotic state and could generate early cleavage embryos when transplanted into
enucleated oocytes (Briggs and King, 1952). Later they used frog cells from several
stages of embryonic development as donors to determine whether differentiated cells
retain the same developmental potential as the zygote (Briggs and King, 1957).
Interestingly, they observed a gradual decline in cloning efficiency with increased donor
cell differentiation. In later studies, analysis of cell morphology and marker gene
expression were used to more accurately define the origin and differentiation state of the
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Figure 2: Murine nuclear transfer by microinjection. a) Schematic drawing of the NT
procedure. The inner cell mass (ICM) will give rise to embryonic stem cells, when
explanting the blastocyst onto irradiated feeder cells. Alternatively, when transferred to
a synchronized pseudopregnant female, the blastocyst can generate a mouse. The outer
cells of the blastocyst, the trophectoderm, will give rise to the extraembryonic tissues
(placenta) and the ICM cells will generate the embryo. b-k) The same steps as in a)
shown by light microscopy.
(ICM: inner cell mass; TE: trophectoderm)
TE
ICM
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donor cell -- a critical issue in resolving the question of nuclear potency (Hochedlinger
and Jaenisch, 2002b). Although Gurdon succeeded in generating adult frogs from
embryonic cells in 1962, adult donor cells have not produced any live frog clones,
suggesting that adult cells, in contrast to embryonic cells, lack nuclear totipotency
(Hochedlinger and Jaenisch, 2002b).
Despite the early successes in amphibian cloning, the development and
application of nuclear transplantation in mammals did not make much headway (Fig. 3).
The first attempt to clone mammals was reported in 1975 (Bromhall, 1975). Bromhall
used both microinjection and virus-induced fusion of morula cells with unfertilized rabbit
Figure 3: Timeline of key events in the application of nuclear
transfer and stem cell research
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eggs. In both cases, only early cleavage could be observed. Although Bromhall did not
enucleate the eggs prior to microinjection, he reported some cases of stochastic self-
enucleation. This suggested that the donor nucleus could support early development. In
1983, McGrath and Solter successfully transplanted zygotic nuclei into previously
enucleated zygotes using cell fusion. This demonstrated the feasibility of the
transplantation technique in mice (McGrath and Solter, 1983). The reconstructed
embryos developed at a frequency comparable to wildtype embryos. However, later
attempts to use blastomeres as donors failed, leading McGrath and Solter to speculate that
cloning in mammals would not work (McGrath and Solter, 1984).
Table 1: Animals cloned from embryonic, foetal and adult donor cell by
nuclear transfer in the past decade. *ACT: Advanced Cell Technology;
Lanza et al. ** Texas A&M University
Chapter 1- Introduction Nuclear Transfer
19
Breakthroughs in mammalian cloning in the years following these early
experiments included the generation of live lambs, cattle and pigs. All cases were based
on nuclear transplantation using nuclei from blastomeres as donors (reviewed in
(Campbell et al., 2005)). Although these reports were milestones in mammalian cloning,
they still did not address the question whether adult cells are able to give rise to an entire
organism (and therefore retain nuclear totipotency). Ten years after the successful
generation of lambs by NT of blastomere nuclei, Campbell and colleagues reported
another success: the first sheep to be derived by NT using donor nuclei from an
embryonic cell line (Campbell et al., 1996). In 1997, the same group reported a further
breakthrough -- the cloning of “Dolly”, the first mammal cloned from an adult cell
(Wilmut et al., 1997). During the last eight years, considerable progress has been made in
the technology of cloning and in the understanding of its species-specific requirements.
Researchers have successfully generated cloned offspring from 15 additional species,
using both embryonic and adult donor cells (Table 1) (reviewed in (Campbell et al.,
2005);(Lee et al., 2005)).
Cloning and differentiation
In their early studies, Briggs and King had observed that differentiating frog cells
progressively lose their nuclear potency (Briggs and King, 1957). To date, no frogs have
been cloned from adult cells. This raises the question whether mammalian clones,
including Dolly, are really derived from differentiated cells or from rare adult stem cells.
Dolly’s donor cells, as well as the somatic cells used to generate clones in subsequent
years, originated from adult animals. There was, however, no conclusive evidence that
the donor cells had been fully differentiated (Hochedlinger and Jaenisch, 2002b).
The unequivocal demonstration that terminally differentiated cells can give rise to
an NT-derived organism was established using lymphocytes as donor cells (Hochedlinger
and Jaenisch, 2002a). In lymphocytes, immunoglobulin (Ig) and T-cell receptor (TCR)
gene rearrangements serve as endogenous markers for both the origin and the
differentiation state of the donor cell. The NT-derived monoclonal mice displayed unique
Ig or TCR rearrangements in every tissue demonstrating that the donor cells were indeed
fully differentiated (Hochedlinger and Jaenisch, 2002a). Eggan and colleagues later
cloned mice using nuclei form terminally differentiated olfactory neurons. They
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demonstrated that even nuclei from post-mitotic donor cells can re-enter the cell cycle
and generate viable clones (Eggan et al., 2004). However, due to the low NT efficiency
of the donor cells, these studies first derived NT-ES cells. Hochedlinger and Jaenisch
then generated cloned mice by implementing a second step in which tetraploid
blastocysts were injected with NT-ES cells. This ensured that the resulting offspring was
entirely derived from the ES cells. In this procedure, all extra-embryonic tissues were
derived from the tetraploid cells. To demonstrate that terminally differentiated cells can
generate each and every kind of embryonic and extra-embryonic lineages, Eggan and
colleagues subjected the olfactory neuron-derived NT-ES cells to a second round of
nuclear transfer. More recently, it was shown that terminally differentiated NKT cells can
be directly cloned (Inoue et al., 2005). NKT cells, like B and T cells, have genetic
rearrangements that allow retrospective identification of the differentiation state of the
cells. It is worth mentioning that, even though T cells and NKT cells are part of the same
cell lineage, their respective NT efficiency is significantly different (Hochedlinger and
Jaenisch, 2002a; Inoue et al., 2005).
Why is cloning so inefficient?
Based on the progress in cloning over the past decade, it has to be assumed that,
given the appropriate conditions, almost any donor cell type can be used for NT.
Furthermore, it should be possible to generate offspring using NT from most, if not all,
species. However, the overall cloning efficiency remains extremely low: only an
estimated 0-5% of reconstructed embryos develop to term (Campbell et al., 2005). The
first mouse clones were generated more than 7 years ago (Wakayama et al., 1998) and
many different laboratories now conduct murine nuclear transfer experiments. The
efficiency of mammalian cloning has not significantly improved, despite great efforts to
this effect. In addition to the inefficiency of the cloning procedure, there is the possibility
that normal clones do not exist. It is conceivable that the few clones that survive are
simply less abnormal than those that do not survive (Jaenisch, 2004). There are several
possible explanations for the inability of the donor nucleus to generate functional clones.
Technical issues, such as the handling, isolation and type of the donor cell, as well as the
subsequent activation and culture conditions, probably impact cloning efficiency. There
are also important biological barriers, such as non-equivalence of the maternal and
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paternal genomes. These barriers will be more difficult to resolve than any technical
limitations (Jaenisch, 2004).
As a result of natural fertilization, the genetic content of a zygote is inherited by
all somatic cells of the developing organism. However, only a subset of genes is active in
a given cell type. For normal development to proceed, it is crucial that in a particular cell,
all essential genes are switched on, while those that are not required are switched off.
Many of the genes crucial to early development, such as Oct-4 have already been
identified. Recent studies show that somatic cell-derived NT blastocysts often fail to
reactivate many of these crucial genes (Boiani et al., 2002; Bortvin et al., 2003).
Gene expression is regulated by epigenetic mechanisms such as DNA methylation
and chromatin modifications that impose stable but reversible marks on the genome.
Such stable alterations resulting in differential gene expression are often referred to as
“epigenetic” (Wang et al., 2004). A key factor in cloning-associated abnormalities
probably involves inadequate epigenetic reprogramming of the donor genome. DNA
methylation, one of the best-studied epigenetic modifications, is known to be aberrant in
many clones (see below). Recent work by Blelloch et al. supports the central role of
DNA methylation: global hypomethylation of the donor cell before NT was shown to
significantly increase the efficiency of ES cell derivation (Blelloch et al., submitted).
Another study showed significant improvements in cloning efficiency and NT-ES
cell development after trichostatin-A (TSA) treatment of  the reconstructed oocyte. TSA
is a compound that increases histone acetylation and DNA demethylation (Kishigami et
al., 2006). A better understanding of the reprogramming factors and events that occur in
the oocyte should help further improve efficiency of nuclear transfer.
Biological NT applications
Nuclear transplantation was originally developed to study the question of nuclear
equivalence (Briggs and King, 1952). The technique allows the in-vivo amplification of a
single cell into an entire organism. It thus constitutes a powerful tool for dissecting
genetic and epigenetic regulatory mechanisms within the genome.
The cloning of mice from lymphocytes, for example, made it possible to study the
process of allelic regulation (Gerdes and Wabl, 2004) and secondary Ig rearrangements
(Koralov et al., 2005) in monoclonal mice. Similarly, nuclear transfer has been used to
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determine whether the variety of olfactory receptors is created by gene rearrangements in
a fashion similar to the generation of antibody diversity in the immune system. This
question was originally contemplated because of parallels between the immune system
and the brain, such as a requirement for the non-homologous end-joining (NHEJ)
machinery and Rag1 expression in both lymphocytes and neurons, as well as the presence
of a vast number of different receptors in the olfactory epithelium. To address this
question, Eggan and colleagues used olfactory sensory neurons as NT donors to produce
cloned mice (Eggan et al., 2004). The resulting data suggested that genetic
rearrangements do not occur in olfactory neurons.
One intriguing question recently addressed by NT was the contribution of
epigenetic changes in the development of cancer and whether such changes could be
reprogrammed to alter the cancer phenotype. A study by Hochedlinger et al., showed that
several tumour cell lines could support the pre-implantation development, but not the
derivation of ES cells. One melanoma cell line generated pluripotent ES cells and
contributed to chimeras when injected into diploid blastocysts. It is interesting that the
tumour phenotype was similar to that of the original cell line, but showed higher
penetrance and shorter latency. This demonstrated that the secondary changes in the
melanoma cell line are compatible with a wide spectrum of development, but that they
also predispose the cells to transformation (Hochedlinger et al., 2004).
In a second study, NT of embryonic carcinoma (EC) cells was used to compare
the role of epigenetic and genetic alterations in tumorigenicity and in the developmental
potential of EC cells respectively. Although EC cell lines generated NT-ES lines with
great efficiency, the tumorigenic and developmental potential in the latter remained the
same as in the donor EC cells. This suggested that irreversible genetic changes, rather
than epigenetic modifications, determined the phenotype of EC cells (Blelloch et al.,
2004).
Commercial NT applications
As well as providing a tool for studying developmental biology, nuclear transfer
has great potential for agricultural technology, the propagation of endangered species,
and for therapeutic applications.
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Transplantation of a nuclear transfer-derived blastocyst to the uterus of a recipient
female will, in some cases, generate live offspring. Nuclear transfer in human is a highly
controversial theme. Apart from ethical objections, animal experiments have already
shown that such endeavours are dangerous. These findings have resulted in the broad
consensus among scientists that cloning humans for reproductive purposes would be
irresponsible (Jaenisch and Wilmut, 2001).
Many important farm animals such as cattle, pigs and sheep have been successfully
cloned using this technique (Campbell et al., 2005). Nuclear transfer also allows the
simple propagation of ,,elite” strains of animals. Among other reasons, the lack of ES or
ES-like cells that can contribute to the germline in sheep and in other farm animals made
the generation of sheep by NT from a cell line so important (Campbell et al., 1996). Cell
lines now allowed similar manipulations of farm animal genomes that are readily
available in the mouse. This approach was successfully used to produce transgenic sheep,
pigs and cows in the years to follow (Campbell et al., 2005).
It should be emphasized that abnormalities, though present in the cloned animal, are
epigenetic and therefore not problematic for the propagation of farm animals. Current
evidence indicates that all epigenetic abnormalities can be corrected in the germline and
the offspring can therefore be completely normal and healthy (Jaenisch, 2004).
Finally, it is worthy of note that endangered species such as a Gaur have been
cloned using domestic animals as oocyte donors (Lanza et al., 2000), demonstrating
another useful application of NT.
Therapeutic NT applications
When a NT blastocyst is explanted it can, under certain conditions, generate
customized pluripotent NT-ES-cell lines which have great potential for regenerative
medicine. Stem cells are generally defined as cells with the ability to self renewal and to
generate more restricted, differentiated cells. The two major classes of stem cells are
adult and embryonic stem cells. In the adult, many tissues, including the intestine and the
haematopoetic system, have a significant turnover. This remarkable ability to regenerate
is provided by rare, quiescent stem cells that can give rise to the manifold cell types of
their respective tissue. They are generally thought to be restricted to that lineage (Wagers
and Weissman, 2004). There have also been a few reports suggesting that adult stem cells
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have greater developmental potential, and that they can transdifferentiate into other cell
lineages. However, the ability of these cells to generate cells of other lineages remains
very controversial (Wagers and Weissman, 2004).
One major limitation of adult stem cells is that, once they have been removed
from their biological niches, it is difficult to expand and maintain them in a multipotent
state. By contrast, embryonic stem cells grow in culture for unlimited passages, while
maintaining the potential to generate every single cell type in the body. Indeed, a single
embryonic stem cell can generate an entire mouse (Wang and Jaenisch, 2004).
The first murine ES cells were derived independently by two groups in 1981
(Evans and Kaufman, 1981; Martin, 1981). Shortly after these initial reports, murine ES
cells were shown to contribute to all tissues. Above all, they can contribute to the
germline and therefore to the offspring of chimeras (Bradley et al., 1984). The first
human ES cell line was reported by Thomson and colleagues almost two decades after
the derivation of murine ES cells (Thomson et al., 1998). Two years later, Munsie et al.
reported the derivation of NT-ES cells from somatic cells in the mouse (Munsie et al.,
2000).
The first breakthrough in using nuclear transfer for therapy was demonstrated by
Rideout and colleagues (Rideout et al., 2002), who derived NT-ES cells from an
immunodeficient mouse. The immunodeficiency defect was corrected by homologous
recombination. The repaired NT-ES cells were then differentiated in vitro into
haematopoetic precursors and then transplanted back to the donor mouse. This procedure
indeed restored normal lymphocyte populations in the mouse, constituting the proof of
principle that NT can be used for therapeutic applications. This was further supported by
another study that used NT-ES cell-derived dopaminergic neurons to ameliorate disease
in a mouse model of Parkinson disease (Barberi et al., 2003). These studies highlight
NT’s great potential for stem cell therapies. However, many technical and safety issues
must still be addressed before these findings can be translated into human therapy.
Alternative approaches for reprogramming somatic cells
While research in mammalian nuclear transfer is making progress, alternative
ways of de-differentiating somatic cells might also prove useful. NT represents the most
extreme form of nuclear reprogramming. Alternative approaches, such as cell fusion,
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allow the de-differentiation of somatic cells, and thus the generation of pluripotent hybrid
cells. When a less differentiated cell is fused with a differentiated cell, the former
typically dictates the fate of the hybrid. In mouse and humans, fusion of ES cells with
somatic cells results in the formation of pluripotent hybrids (Cowan et al., 2005; Do and
Scholer, 2004; Tada et al., 2001). Do and Scholer took the initial fusion studies
performed by Tada et al. one step further by investigating what part of the ES cell
(cytoplast or karyoplast) harboured the reprogramming activity. Their results suggested
that the reprogramming activity was present only in the karyoplast (Do and Scholer,
2004).
Although these fusion experiments demonstrate the potential of this approach,
they have several drawbacks. The major problem in clinical applications is that the
hybrids resulting from cell fusion are tetraploid. Ideally, the embryonic and somatic
nucleus should remain separate for the time required to accomplish functional
reprogramming. This, however, can only be achieved when efficient reprogramming
occurs without DNA replication and cell division. Do and Scholer fused ES cells to
neurosphere cells treated with mitomycin C to inhibit DNA replication and cell division.
In these experiments, reactivation of the Oct4-GFP reporter was observed only when the
neurospheres were pretreated with a demethylating agent. This suggests that
reprogramming might depend on DNA replication (Do and Scholer, 2004).
In addition, it is unclear whether the data presented in these studies show complete
functional reprogramming of the somatic genome or only partial reprogramming
compensated by the pluripotent ES genome. Although numerous reprogramming events,
such as reactivation of somatic Oct-4 and other genes, have been demonstrated (Cowan et
al., 2005; Tada et al., 2001), this does not necessarily mean that all genes required for a
pluripotent state have been reactivated. However, further investigation will provide new
insight into the reprogramming events after cell fusion.
Cell free nuclear extracts provide another interesting approach for
reprogramming. However, early experiments with human cell lines to determine whether
the somatic genome is reprogrammed have not been convincing. It is possible that
transient protein uptake from the nuclear extracts takes place rather than a reactivation of
endogenous genes and functional reprogramming (Hakelien et al., 2004; Hakelien et al.,
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2002; Taranger et al., 2005). Further studies, using more stringent measures of
reprogramming, will be required to assess the true reprogramming potential of cell
extracts.
Alternative approaches for generating stem cells
Embryonic stem cells are routinely derived from a very early stage embryo
termed the blastocyst (Figs. 2 and 4). Ever since Thomson and colleagues reported the
isolation of the first human embryonic stem cell (hESC) lines (Thomson et al., 1998), the
derivation of new stem cell lines has remained highly controversial. To derive
Figure 4: Altered nuclear transfer (ANT). The ANT procedure is very similar to the regular NT
described in Figure 2. a) The first lineage differentiation takes place after the 8-cell stage. b) The
only modification required for ANT is the introduction of a conditional RNAi system (contains a
GFP cassette; described in Chapter 3) via lentiviral transduction. Due to the presence of the Cdx2
shRNA, no Cdx2 protein can be made and hence the TE cannot form properly. The blastocyst
becomes a disorganized clump of cells and cannot implant, yet it still allows derivation of
pluripotent of ES cells.
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customized ES cells, NT takes the destruction of an intact human blastocyst into account
-- one that could potentially generate a human being. This problem is at the root of the
whole ethical dilemma.
We recently reported an alternative approach to generate NT-ESCs (Meissner and
Jaenisch, 2006). This method, called altered nuclear transfer, was proposed by W.
Hurlbut, a member of the president’s council for bioethics (Hurlbut, 2005). We designed
a simple experimental strategy to test the feasibility of this concept in the mouse (see
Chapter 3). During the first stages of preimplantation development, all blastomeres
remain totipotent. However, after the 8-cell stage, the first lineage differentiation decision
takes place. This decision generates the first two cell lineages: the trophectoderm (TE)
and the inner cell mass (ICM) (Fig. 4a). The latter gives rise to the embryo as well as to
embryonic stem cells when explanted. The TE generates the foetal-maternal interface
(placenta) and trophectoderm stem cells (TS) cells when explanted (Tanaka et al., 1998).
The concept of altered nuclear transfer involves disabling a gene that is essential
for TE function prior to NT, thus eliminating the developmental potential of the
reconstructed embryo (Fig. 4b). In fact, the lack of the TE lineage generates a “biological
artifact” (Hurlbut, 2005), since it creates a disorganized clump of cells. Detailed studies
from the laboratories of Rossant and Beck provided excellent insight into the role of
Cdx2, the earliest known TE-specific transcription factor. Using a recently developed
conditional RNAi system (see Chapter 3), we demonstrated that loss of Cdx2 leads to the
development of abnormal blastocysts that cannot implant. However, the absence of Cdx2
did not affect the ability to derive pluripotent ES cells, and removal of the Cdx2 inhibitor
from the ES cells restored their potency to that of any normal ES cell line.
It has already been shown that human and mouse ES cells can be derived from
morula stage embryos (Strelchenko et al., 2004; Tesar, 2005). A new study now reports
that single 8-cell stage blastomeres can generate pluripotent ES cell lines (Chung et al.,
2006). Although this study is interesting, the reported efficiency was several times lower
than the efficiency of ES cell generation using later stage embryos. The authors
envisioned this technique as a possible way of solving the ethical dilemma of sacrificing
a viable embryo to generate ES cells. They demonstrate that removing a single
blastomere from a murine eight-cell embryo does not affect the developmental potential
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of the manipulated embryo. The single blastomere could thus be used to generate ES cells
and the seven-cell embryo could be transferred to generate a foetus.
Obviously, this procedure, if feasible in humans, would apply only to couples
undergoing in-vitro fertilization (IVF). In addition, the low efficiency of the procedure
means that it is fairly unlikely that every blastomere yields an ES cell line, raising in turn
the question of what to do with the embryos that did not yield a matching ES cell line.
Moreover, in other species it has been shown that single blastomeres are still totipotent.
Thus it could still be argued that destroying a blastomere is equivalent to destroying an
embryo. Indeed, people have used similar rationale to argue against the altered nuclear
transfer approach (Solter, 2005). While it is clearly impossible to please everybody, it
must also be admitted that both approaches provide interesting scientific data as well as a
scientific basis for alternative ways of generating ES cells using more ethical approaches.
DNA methylation and epigenetic reprogramming
Overview
DNA methylation is a key epigenetic modification that provides heritable
information not encoded in the nucleotide sequence. 5-methylcytosine is the only known
covalent modification of DNA in vertebrates (Jeltsch, 2002). Mammalian DNA
methylation serves a wide-range of functions including regulation of gene expression,
genomic imprinting, and X-chromosome inactivation. It contributes to genomic stability
and serves as a defense mechanism against transposable elements (Bestor, 2000b;
Jaenisch, 1997; Jaenisch and Bird, 2003; Robertson and Wolffe, 2000). In addition, its
role in disease states such as cancer becomes increasingly evident (Feinberg, 2004;
Gaudet et al., 2003; Jones and Baylin, 2002; Laird, 2003; Robertson, 2002).
Three catalytically active DNA methyltransferases (Dnmts) have been described
that are responsible for establishing and maintaining methylation patterns in mammals
(Bestor, 2000b; Li et al., 1992; Okano et al., 1999; Okano et al., 1998a). Dnmt1 has been
largely viewed as the maintenance enzyme, owing to its preference for hemimethylated
DNA (Robertson and Wolffe, 2000). Dnmt3a and Dnmt3b have no preference and are
required for de novo methylation activity (Okano and Li, 2002). During murine
preimplantation development methylation levels decrease with some notable exceptions
including imprinted genes and IAP elements (Jaenisch, 1997; Lane et al., 2003). Around
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the time of implantation normal methylation levels are restored by the de novo
methyltransferases and later maintained by Dnmt1.
Targeted gene disruption for each of the catalytically active Dnmts (1, 3a and 3b)
results in a lethal phenotype demonstrating the essential role of DNA methylation in
development (Li et al., 1992; Okano et al., 1999). Interestingly, undifferentiated ES cells
deficient for Dnmt1, Dnmt3a, Dnmt3b or Dnmt3a/3b do not display any obvious
abnormalities (Lei et al., 1996; Okano et al., 1999). Normally in wild-type ES cells most
CpG dinucleotides are methylated with the exception of many CpG-islands.
In addition, ES cells and early embryos, but not somatic cells, seem to contain
significant amounts of non-CpG methylation (mostly CpA) (Haines et al., 2001;
Ramsahoye et al., 2000). Currently the functional role of this non-CpG methylation is not
clear.
In general, methylation is found in CpG-poor regions, while CpG-rich areas (CpG
islands) seem to be protected from this modification and are generally associated with
active genes (Cross and Bird, 1995). This is consistent with the fact that methylated CpG
islands are found on the inactive X chromosome and on the silenced allele of imprinted
genes (Neumann and Barlow, 1996; Razin and Cedar, 1994; Riggs and Pfeifer, 1992).
The methyl group is positioned in the major groove of the DNA where it can easily be
detected by proteins interacting with the DNA (Jeltsch, 2002). The effects of DNA
methylation on chromatin structure and gene expression are likely mediated by a family
of proteins that share a highly conserved methyl CpG-binding domain (MBD) (Wade,
2001). Two of these, MeCP2 and MBD1, have been suggested to be involved in
transcriptional repression (Fujita et al., 2000; Fujita et al., 1999; Nan et al., 1997) based
on biochemical observations that they form complexes with histone deacetylases and
other proteins important for chromatin structure (Jones et al., 1998; Nan et al., 1998;
Wade et al., 1999; Zhang et al., 1999).
DNA methylation during development
DNA methylation patterns are extremely dynamic in early mammalian
development. Within 1-2 cell divisions after fertilization a wave of global demethylation
takes place. It has been suggested that the paternal genome is actively demethylated
during the period of protamine-histone exchange and the maternal genome subsequently
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becomes demethylated, presumably through a passive DNA replication mechanism (Reik
et al., 2001; Santos et al., 2002). By the morula stage, methylation is found only in some
repetitive elements and imprinted genes (Reik et al., 2001; Sanford et al., 1987; Walsh et
al., 1998). After implantation, genome-wide methylation levels increase dramatically,
establishing a differential pattern between the cells of the ICM and those of the
trophectoderm (Santos et al., 2002), and ultimately resulting in the formation of
methylation patterns found in the adult (Turker, 1999). Primordial germ cells (PGC) also
undergo global demethylation. Importantly, in contrast to demethylation during
preimplantation, all parental specific epigenetic marks are erased in the PGC by
embryonic day 13-14. As a result, PGC and diploid germ cells are the only cell type
where the paternal and maternal genomes are equivalent. Upon initiation of
gametogenesis, PGC remethylation begins and the parental-specific methylation patterns
that will code for monoallelic expression of imprinted genes are established (Lucifero et
al., 2002; Reik et al., 2001).
Maintenance and establishment of DNA methylation is accomplished by at least
three independent catalytically active DNA methyltransferases: Dnmt1, Dnmt3a and
Dnmt3b (Bestor, 2000a; Robertson and Wolffe, 2000). There are two isoforms of Dnmt1,
an oocyte specific isoform (Dnmt1o) and a somatic isoform. Somatic Dnmt1 is often
referred to as the ‘maintenance’ methyltransferase because it is believed to be the enzyme
that is responsible for copying methylation patterns after DNA replication. The oocyte
specific isoform of Dnmt1 is believed to be responsible for maintaining but not
establishing maternal imprints. The Dnmt3 family (Dnmt3a, 3b, 3l and a number of
isoforms) is required for the de novo methylation that occurs after implantation, for the
de novo methylation of newly integrated retroviral sequences in mouse ES cells (Bestor,
2000a; Okano et al., 1999), and for the establishment of imprints (Dnmt3l) (Li, 2002). It
was recently shown that Dnmt3a has a strong preference for unmethylated DNA
(Yokochi and Robertson, 2002).
The essential role of DNA methylation in mammalian development is highlighted
by the fact that mutant mice lacking each of the enzymes (generated by gene targeting)
are not viable and die either during early embryonic development (Dnmt1 and Dnmt3b)
or shortly after birth (Dnmt3a) (Li et al., 1992; Okano et al., 1999; Robertson and Wolffe,
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2000). The knockout of Dnmt3l leads to male infertility and the failure to establish
imprints in female eggs (Bourc'his et al., 2001b; Li, 2002). Disruption of Dnmt2 did not
reveal any obvious effects on genomic DNA methylation (Okano et al., 1998b).
DNA methylation and SCNT
Considering the fundamental role of DNA methylation in development, it seems
likely that any NT embryo will need to recapitulate a functional pattern of epigenetic
modifications in order to proceed through normal embryogenesis. Several groups have
investigated DNA methylation patterns in NT embryos and reported finding
abnormalities in DNA methylation (Bourc'his et al., 2001a; Dean et al., 1998; Dean et al.,
2001; Kang et al., 2001a; Kang et al., 2002; Ohgane et al., 2001). In cloned bovine
embryos, satellite sequence methylation levels are more similar to the donor cells than to
control embryos (Kang et al., 2001a). However, methylation patterns of single copy gene
promoters in cloned bovine blastocysts appeared to be normally demethylated (Kang et
al., 2001a). In addition, the satellite sequences, but not the single copy genes, showed
more methylation in TE than in the ICM of cloned bovine blastocysts (Kang et al., 2002)
(reviewed in (Han et al., 2003)). Using antibodies against 5-methyl cytosine two
independent studies showed that the cloned bovine embryos did not undergo global
demethylation in early embryogenesis and even showed precocious de novo methylation
(Dean et al., 2001), with euchromatin being abnormally hypomethylated and centromeric
heterochromatin being abnormally hypermethylated (Bourc'his et al., 2001a). These
findings suggest that different chromosomal regions might respond differently to
demethylation in the egg cytoplasm. Interestingly, when the same satellite sequences
examined in bovine (Kang et al., 2001a) were analyzed in a different species (porcine)
methylation levels at the blastocyst stage of cloned embryos were more comparable to
those of fertilized control embryos (Kang et al., 2001b), suggesting also species-specific
differences. A recent study that analyzed a number of imprinted genes in cloned murine
blastocysts showed that most of the examined genes displayed aberrant methylation and
expression patterns (Mann et al., 2003).
It would be interesting to know if aberrant methylation patterns during
preimplantation development contribute to the low efficiency of generating clones and to
what extent the clones can tolerate such variation. Unfortunately, analyzing the
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methylation status in preimplantation embryos provides only indirect correlations
preventing satisfactory resolution of this question.
In order to establish a potential correlation between global DNA methylation
levels and the developmental potential of cloned embryos, Cezar et al., compared the
genome-wide methylation status among spontaneously aborted cloned fetuses, live cloned
fetuses, and adult clones in bovine (Cezar et al., 2003). When genome-wide cytosine
methylation levels were measured by reverse-phase HPLC, they found that a significant
number of aborted fetuses lacked detectable levels of 5-methylcytosine. In contrast, when
seemingly healthy adult, lactating clones were compared to similarly aged lactating cows
produced by artificial insemination, comparable DNA methylation levels were observed.
The authors suggested that survivability of cloned cattle is related to the global DNA
methylation status. All evidence suggests that a correct global methylation status is
required for development. However, subtle changes might be compatible with normal
development and result only in minor or no phenotypes. For example, by applying
restriction landmark genome scanning (RLGS) in two seemingly healthy cloned mice, it
was shown that methylation patterns at several sites in each clone differed from those in
the controls (Ohgane et al., 2001).
The reason for the frequent abnormal DNA methylation patterns in cloned
embryos is still unclear. It is likely that, because of the epigenetic difference between the
somatic donor cell and the gametes, the somatic nucleus responds differently to the egg
cytoplasm, affecting subsequent events during embryogenesis. For example, the highly
coordinated demethylation process in the pronuclei of the maternal and paternal genome
upon fertilization might not happen appropriately in the somatic donor genome following
NT. It is not clear whether all of the somatic epigenetic marks imposed by DNA
methylation during differentiation can be removed from the donor nucleus. Any failure to
demethylate the DNA sequences that are normally demethylated during early cleavage
stages of development might be stably passed on to progeny cells. Another possible
explanation for the aberrant methylation patterns in clones may result from the ectopic
expression of the somatic form of Dnmt1 in the egg and cleavage stage cloned embryos.
In the mouse oocyte and preimplantation embryo, the oocyte specific form (Dnmt1o) but
not the longer somatic form is expressed. It has been shown that a translocation of
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Dnmt1o between nucleus and cytoplasm is tightly regulated during murine
preimplantation development (Howell et al., 2001; Ratnam et al., 2002). In contrast,
cloned preimplantation mouse embryos were reported to aberrantly express the somatic
form of the Dnmt1 gene, and the translocation of Dnmt1o was absent (Chung et al.,
2003). As mentioned above, DNA methyltransferases (Dnmt1, 3a, 3b 3l) play important
roles in setting up and maintaining DNA methylation patterns. It is reasonable to
speculate that dysregulation of any of these enzymes in clones may alter DNA
methylation patterns.
These abnormal DNA methylation patterns could result in embryo lethality or
phenotypic abnormality. At present, little is known about the developmental role of
dynamic changes in DNA methylation during preimplantation, although very recently,
the importance of early embryonic methylation patterns in setting up the structural profile
of the genome was shown (Hashimshony et al., 2003). This suggests that the failure to
establish correct methylation patterns early in development might have far reaching
effects on the chromatin structure. Interestingly, mouse embryos deficient for Dnmt1 and
Dnmt3b die around E9.5 (Li et al., 1992; Okano et al., 1999), but Lsh mutant mice die
only after birth despite showing a substantial loss of methylation throughout the genome
(Dennis et al., 2001).
Analyzing DNA methylation
The intense interest in the biological functions of DNA methylation and its role in
diseases have led to numerous techniques to detect and compare DNA methylation
(reviewed in (Laird, 2003; Murrell et al., 2005)). Global methods such as nearest
neighbor analysis (NNA) and high-performance liquid chromatography are valuable to
quantify the total 5-methylcytosine content of a DNA sample, but information on the
position in the genome cannot be gained (Ramsahoye, 2002a; Ramsahoye, 2002b).
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Digestion with methylation-sensitive (or methylation-dependent) restriction
enzymes (MSREs) has been used to selectively enrich the methylated and unmethylated
DNA fractions, respectively (Bedell et al., 2005; Lippman et al., 2004; Lippman et al.,
2005; Strichman-Almashanu et al., 2002; Yamada et al., 2004). Similarly, methylation-
dependent restriction in a cloning host has been employed as a filter against methylation-
Figure 5: Differential base modification by sodium bisulfite. A hypothetical DNA strand
containing cytosine and 5-methyl-cytosine residues. Single stranded DNA is generated using
NaOH. After adding sodium bisulfite all cytosine residues are converted to uracil by the
mechanism shown. The 5-methyl-group protects against the sulphonation and therefore every
methylated cytosine remains unchanged. After complete reaction the DNA strands are not
complimentary anymore. Hence, each strand is amplified by PCR using different primer sets that
are specific for the converted sequences. The PCR products are cloned into a plasmid vector and
sequenced. The sequences can be aligned to the original sequence: C-T mismatches indicate
unmethylated cytosines, whereas C-C matches indicate a methylated cytosine
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rich sequences in clone libraries (Rabinowicz et al., 1999). Another, more recent genome-
wide approach used immunopreciptation with a methyl cytosine antibody rather than
restriction digestion to enrich for the methylated fraction (Weber et al., 2005). The
enriched genome fractions are analyzed by sequencing or by array-hybridization
(Lippman et al., 2004; Lippman et al., 2005). MSRE-based methods are somewhat
indirect in that they discriminate for or against methylation at the recognition site of the
particular enzyme used and cannot directly reveal the methylation status of cytosines or
CpG dinucleotides outside the restriction site.
In contrast, methylation-sensitive chemical reactions have no specific recognition
sequence. Sodium bisulfite efficiently deaminates unmethylated cytosine to uracil
without affecting 5-methyl cytosine (Fig. 5). In recent years, PCR amplification and
sequencing of bisulfite-converted genomic DNA has emerged as the gold standard for
analyzing and comparing methylation patterns at specific loci (Frommer et al., 1992).
Despite these technological advances, in the absence of systematic sequence-
based methylation analyses, the genomic methylation landscape in mammals is still
largely unexplored. Therefore, the potential diagnostic value of specific methylation
differences remains largely untapped.
The human epigenome project (HEP) is aimed at generating a high-resolution
DNA methylation map of the human genome (Novik et al., 2002; Rakyan et al., 2004).
To achieve this goal the bisulfite sequencing technique has been scaled-up in a targeted
fashion using locus-specific PCR primers. We describe a new random approach for large-
scale high-resolution DNA methylation analysis termed reduced representation bisulfite
sequencing (RRBS) in the last part of Chapter 3.
DNA methylation and disease
Aberrant methylation patterns as a result of incomplete epigenetic reprogramming
have been implicated in the abnormal development after NT (see above). ES cells are
epigenetically unstable with many imprinted genes affected (Humpherys et al., 2001).
Recent work has demonstrated a link between loss of imprinting (LOI), in particular Igf2,
and tumorigenesis (Sakatani et al., 2005).
Most human cancers display genome-wide hypomethylation and concomitant
promoterspecific tumor suppressor gene hypermethylation (Feinberg, 2004; Gaudet et al.,
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2003; Jones and Baylin, 2002; Laird, 2003; Robertson, 2002). Generation of mice
carrying a hypomorphic allele for Dnmt1 demonstrated that global hypomethylation
resulted in aggressive T cell lymphomas that displayed a high frequency of chromosome
15 trisomy. These results indicated that DNA hypomethylation plays a causal role in
tumor formation, possibly by promoting chromosomal instability (Gaudet et al., 2003).
Using conditional inactivation of de novo methyltransferase Dnmt3b in Apcmin/+
mice, our lab has demonstrated that loss of Dnmt3b has no impact on microadenoma
formation, which is considered the earliest stage of intestinal tumor formation. However
we observed a significant decrease in the formation of macroscopic colonic adenomas.
Interestingly many large adenomas showed regions with Dnmt3b inactivation, indicating
that Dnmt3b is required for initiation of macroscopic adenomas but is not required for
their maintenance. Also Dnmt3b inactivation in normal colonic epithelium had no
adverse effect on tissue homeostasis. These results support a role for Dnmt3b in the early
stages of macroscopic colonic tumor initiation and suggest that it is not required for later
tumor maintenance (Lin et al., 2006).
Consistent with the notion that both promoter hypermethylation and genome-wide
hypomethylation are functionally important in tumorigenesis, genetic and or
pharmacologic reduction of DNA methylation levels results in suppression or promotion
of tumor incidence, respectively, depending on the tumor cell type. For instance, DNA
hypomethylation promotes tumors that rely predominantly on loss of heterozygosity
(LOH) or chromosomal instability mechanisms, whereas loss of DNA methylation
suppresses tumors that rely on epigenetic silencing. Mutational and epigenetic silencing
events in Wnt pathway genes have been identified in human colon tumors. ApcMin/+ mice
were recently used to investigate the effect of hypomethylation on intestinal and liver
tumor formation. Intestinal carcinogenesis in ApcMin/+ mice occurs in two stages, with the
formation of microadenomas leading to the development of macroscopic polyps. Using
Dnmt1 hypomorphic alleles to reduce genomic methylation, showed an elevated
incidence of microadenomas that were associated with LOH at Apc. In contrast, the
incidence and growth of macroscopic intestinal tumors in the same animals was strongly
suppressed. In contrast to the overall inhibition of intestinal tumorigenesis in
hypomethylated ApcMin/+ mice, hypomethylation caused development of multifocal liver
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tumors accompanied by Apc LOH. These findings support the notion of a dual role for
DNA hypomethylation in suppressing later stages of intestinal tumorigenesis, but
promoting early lesions in the colon and liver through an LOH mechanism (Yamada et
al., 2005).
Parts of this chapter have been published:
Meissner, A. and Jaenisch, R. From frog cloning to the generation of customized ES
cells. BIF Futura (2006). In press
Wang, Z.*, Meissner, A.*, and Jaenisch, R. Nuclear Cloning and Epigenetic
Reprogramming. Handbook of Stem Cells. Academic Press (2004)
*equal contributing authors
Chapter 2- Methods and Materials Plasmids
38
Chapter 2- Materials and Methods
Generation of plasmids
To generate pSico the lox-CMV-GFP-lox cassette was removed from lentilox 3.7
(pLL3.7) (Rubinson et al., 2003) by digesting with BfuAI and PciI, followed by filling-in
and religation. The first TATAlox followed by the terminator and by an EcoRI was
inserted in the resulting plasmid by PCR-mediated mutagenesis using the following
oligos: pSico6Eco GAATTCAACGCGCGGTGACCCTCGAGG; and pSico6
ASAAAAAACCAAGGCTT-
ATAACTTCGTATAATTTATACTATACGAAGTTATAATTACTTTACAGTTACCC.
To insert the second TATAlox preceded by a NotI site the resulting plasmid was
digested with EcoRI and XhoI and ligated to the following annealed oligos: TATALOX
F: AATTCGAGAGGCGGCCGCATAACTTCGTATAGTATAAATTATACGAAGTT-
ATAAGCCTTGTTAACGCGCGGTGACCC; and TATALOX R: TCGAGGG-
TCACCGCGCGTTAACAAGGCTTATAACTTCGTATAATTTATACTATACGAAGT
TATGCGGCCGCCTCTCG.
The resulting construct was finally digested with EcoRI and NotI and ligated to an
EcoRI-CMV-GFP-NotI cassette to generate pSico. A similar strategy was employed to
generate the various “test” constructs shown in Figure 7. Primer sequence and details are
available upon request.
To generate pSico Reverse (pSicoR) the 5’ loxP site present in pLL3.7 was
removed by digesting with XhoI and NotI and replaced with a diagnostic BamHI site
using the following annealed oligos: Lox replace for TCGAGTACTAGG-
ATCCATTAGGC and Lox replace rev GGCCGCCTAATGGATCCTAGTAC.
A new lox site was inserted 18 nt upstream of the proximal sequence element
(PSE) in the U6 promotor by PCR-mediated mutagenesis.
Oligos coding for the various shRNAs were annealed and cloned into HpaI-XhoI
digested pLL3.7, pSico and pSicoR. Oligo design was as described (Rubinson et al.,
2003). The following target regions were chosen: Nucleophosmin (Npm),
GGCTGACAAAGACTATCAC; Luciferase, GAGCTGTTTCTGAGGAGCC; DNA
methylatransferase 1 (Dnmt1), GAGTGTGTGAGGGAGAAA; and P53,
GTACTCTCCTCCCCTCAAT.
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The CD8 oligo sequence was the same described in (Rubinson et al., 2003). All
constructs were verified by DNA sequencing. To amplify recombined and unrecombined
vector the following oligos were used: Loopout F, CCCGGTTAATTTGCATATAA-
TATTTC; and Loopout R: CATGATACAAAGGCATTAAAGCAG.
Antibodies, chemicals, flow cytometry and western blotting
Anti-α-tubulin antibody was from Sigma, the p53 antibody was a kind gift by K.
Helin (European Institute of Oncology, Milan), and the anti-Npm was a gift from P. G.
Pelicci (European Institute of Oncology, Milan) and E. Colombo (European Institute of
Oncology, Milan). All mouse antibodies used were monoclonal. Doxorubicin and
doxycycline were obtained from Sigma.
To assess expression of CD4 and CD8 in mice, single-cell suspensions of
splenocytes were blocked with anti-CD16 CD32 for 10 min on ice. After blocking, the
cells were incubated with phycoerythrin-conjugated anti-CD8, allophycocyanin-
conjugated anti-CD4, and PerCPCy5.5-conjugated anti-CD3 for 20 min at 4°C (BD
Pharmingen, San Diego). Acquisition of samples was performed on a FACScan flow
cytometer, and the data were analyzed with CELLQUEST software (BD
Immunocytometry Systems, San Jose, CA). Plots were gated on CD3 cells.
For cell-cycle analysis, 106 cells were fixed in 70% ethanol, washed in PBS, and
resuspended in 20 µg/ml propidium iodide (Sigma) and 200 µg/ml RNAseA in PBS.
For western blotting cells were lysed in a buffer containing 1% TritonX-100,
10mM TrisCl and 140mM NaCl and a protease inhibitor cocktail (SIGMA). Proteins
were resolved by SDS-PAGE, transferred to a filter, blocked overnight in 5% fat-free
milk in TBS 0.1% Tween (TBS-T). After 1h incubation with the primary antibody filters
were washed in TBS-T, incubated 30 minutes with the appropriate HRP-conjugated
secondary antibody, washed 3 times in TBS-T and processed using the ECL plus kit and
exposed to film.
Luciferase assay
For reporter assay, 293T cells were cotransfected in 12-well plates by using
FuGENE 6 with the appropriate shRNA vectors together with pGL3control and
pRLSV40. The total amount of transfected DNA was 500 ng per well. Firefly and Renilla
luciferase activity were measured 36 h after transfection by using the dual reporter kit
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(Promega) according to the manufacturer’s instruction. All experiments were performed
in triplicate.
Immunocytochemistry
Cells plated on glass coverslips that had been pre-incubated with 0.1% gelatin in
PBS at 37˚C for 30 minutes were fixed in 4% paraformaldehyde (in PBS) for 10 minutes,
washed with PBS and permeabilized by incubating in PBS 0.1% Triton X-100 for 10
minutes at room temperature. To prevent non-specific binding of the antibodies, cells
were then incubated with PBS in the presence of 5% Bovine Serum Albumin (BSA) for
30 minutes. The coverslips were then gently deposited, face down, on 100 µl of primary
antibody diluted in PBS 5% BSA. After one-hour, coverslips were washed three times
with PBS (5 minutes per wash). Cells were then incubated 30 minutes at RT with the
appropriate secondary antibody Cy3 (Amersham), Alexa 488- or Alexa 350-conjugated
(Molecular Probes). Coverslips were mounted in a 90% glycerol solution containing
diazabicyclo-(2.2.2)octane antifade (Sigma) and examined by fluorescence microscopy.
Images were further processed with the Adobe Photoshop software (Adobe).
Southern blot and methylation analysis
DNA was isolated from the indicated ES cell lines. To assess the levels of DNA
methylation, genomic DNA was digested with HpaII, and hybridized to pMR150 as a
probe for the minor satellite repeats (Chapman et al., 1984), or with an IAP-probe (Walsh
et al., 1998). For the methylation status of imprinted genes, a combined bisulfite
restriction analysis (COBRA) assay was performed with the CpGenome DNA
modification kit (Chemicon) using PCR primers and conditions described previously
(Lucifero et al., 2002). PCR products were gel purified, digested with BstUI or HpyCH4
IV and resolved on a 2% agarose gel. NNA was done as previously described
(Ramsahoye, 2002b).
Northern blots
For the small RNA Northern blotting, 15 µg total RNA isolated with TRIzol
(Invitrogen) according to the manufacturer’s instructions, and was resolved on a 15%
denaturing polyacrylamide gel, transferred to a nylon membrane, and was cross linked by
using the autocrosslink function of a Stratalinker. The membrane was hybridized
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overnight to a 32P 5’-labeled DNA probe corresponding to the 19-nt sense strand of the
p53 shRNA (GTACTCTCCTCCCCTCAAT). Hybridization and washes were performed
at 42˚C.
For detection of the p53 mRNA, 15 µg of total RNA was resolved on an agarose-
formaldehyde gel, transferred to a nylon membrane, and hybridized to a probe
corresponding to the entire p53 coding sequence.
Cloning and design of shRNAs
shRNAs were designed using the pSicoOligomaker 1.5 (developed by Andrea
Ventura/Jacks lab), which is freely available at
http://web.mit.edu/ccr/labs/jacks/protocols/pSico.html. Cloning into pSico and pSicoR
was done as described on the website.
Generation of lentivirus, infection and Cre-mediated recombination
Lentiviruses were generated essentially as described (Rubinson et al., 2003).
Briefly, 5 µg of lentiviral vector and 2.5 µg of each packaging vector were cotransfected
in 293T cells by using the FuGENE 6 reagent (Roche Diagnostics). Supernatants were
collected 36–48 h after transfection, filtered through a 0.4- µm filter, and used directly to
infect MEFs. Two rounds of infection 8 h apart were usually sufficient to infect 90% of
cells. GFP-positive cells were sorted 3–4 days after infection. For ES cell infection, the
viral supernatant was centrifuged at 25,000 rpm in a Beckman SW41t rotor for 1.5 h, the
viral pellet was resuspended in 200 µl of ES cell medium, and was incubated 6 h at 37°C
with 10,000–20,000 cells. After infection, ES cells were plated in 10-cm dishes with
feeders and GFP-positive colonies were isolated 4–5 days later. On average, 10–30% of
ES colonies were GFP-positive. Recombinant adenoviral stocks were purchased from the
Gene Transfer Vector Core facility of University of Iowa College of Medicine (Iowa
City, IA). Infections were performed by using 100 plaque-forming units of virus per cell.
The number of integrations was determined by Southern blot analysis. Genomic DNA
was digested with XbaI (single cut in the viral backbone) and probed with an EGFP-
probe.
Cre-mediated recombination was achieved by transiently tranfecting a Cre-
recombinase containing plasmid. Briefly, after introducing the Cre plasmid into the ES
cells by electroporation, cells were cultured for 24h (not longer, to avoid random
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integration of plasmid) in ES medium plus puromycin. GFP-negative subclones were
picked, expanded and tested for recombination (Cdx21Lox).
Immunohistochemistry and RT-PCR
Cdx2 staining of blastocysts was done as described in (Strumpf et al., 2005). The
protocol is available on the Rossant laboratory website
(http://www.mshri.on.ca/rossant/protocols/immunoStain.html). Monoclonal anti-Cdx2
(CDX2-88, BioGenex, CA, USA) was used for all Cdx2 stainings. RT-PCR was done
with a One-Step RT-PCR Kit (Qiagen) using the following primer: β-actin 5-
ggcccagagcaagagaggtatcc-3 (forward) and 5-acgcacgatttccctctcagc-3 (reverse), Oct-4
(333bp) ggatggcatactgtggacct (forward) and agatggtggtctggctgaac (reverse), Cdx2
(225bp) AAACCTGTGCGAGTGGATG (forward) and
CTGCGGTTCTGAAACCAAAT (reverse). β-actin RT primer were published in ref.
(Strumpf et al., 2005), and Oct-4 and Cdx2 primer were design using PRIMER3.
Nuclear transfer, embryo transfer, ES cell derivation and 2N/4N blastocyst
injections
Nuclear transfer was done as described (Eggan et al., 2001a; Wakayama et al.,
2005). Nuclear transfer embryos were transferred at day 3.5 (morula/blastocyst stage)
into the uteri of day 2.5 pseudo-pregnant recipient females. For ES cell derivation, the
zona pellucida was removed using acidic tyrode (AT) solution and blastocyst were
explanted on irradiated feeders in ES medium plus MEK1 inhibitor (PD98059). Diploid
and tetraploid blastocyst injections were done as described in (Wang and Jaenisch, 2004).
ES cell manipulation
ES cells were cultivated on irradiated mouse embryonic fibroblasts (MEFs) in
DMEM containing 15% fetal calf serum, leukemia inhibiting factor,
penicillin/streptomycin, L-glutamine, and non-essential amino acids. All ES cells were
depleted of feeder cells for two passages on 0.2% gelatine before isolating DNA.
RRBS library construction and sequencing
Mouse ES DNA (50-100 µg) was digested to completion by overnight incubation
with 1,000 units of BglII and electrophoresed on a 1.8% agarose gel. Marker lanes were
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stained with SYBR Green (Invitrogen). A narrow slice containing the 500-600 bp
fraction was excised from the unstained preparative portion of the gel. DNA was
recovered by electroelution, phenol extraction and ethanol precipitation as described
elsewhere (Garnes, 2002). Typical yields were 300-600 ng of size-selected BglII
fragments as measured by PicoGreen fluorescence (Invitrogen). The size-selected BglII
fragments (1-2 pmol) were ligated to 700 pmol BglII adapter pre-annealed from
oligodeoxynucleotides 5’-AGTTATTCCGGACTGTCGAAGCTGAATGCCATGG and
5’-pGATCCCATGGCATTCAGCTTCGACAGTCCGGAAT in 70 µl containing 2,400
units T4 DNA ligase (New England Biolabs) for 16 h at 14°C. Excess adapter was
removed by ultrafiltration (Millipore Montage) followed by preparative electrophoresis in
2% agarose and electroelution, yielding 50-100 ng of adapter-ligated material.
Adapter-ligated, size-selected BglII fragments (50 ng) were bisulfite-treated using
the reagents and protocol of the CpGenome DNA modification kit (Chemicon) with the
following modifications: the DNA was alkali-denatured for 20 min. at 55°C; the total
reaction volume was increased from 650 µl to 750 µl and contained 0.22 g urea (Paulin et
al., 1998) ; the mixture was incubated for 24 h at 55°C. After alkaline desulfonation and
final desalting, single-stranded uracil-containing reaction products were eluted in 40 µl of
TE buffer and converted to double-stranded DNA by PCR with primers 5’-
TTGGATTGTTGAAGTTGAATG and 5’-
AAACTATCAAAACTAAATACCATAAAATC designed to amplify molecules
carrying bisulfite-modified adapter sequences at both ends. For each bisulfite reaction,
eight 50 µl PCRs were performed, each containing 2.5 µl bisulfite-treated DNA, 25 pmol
of each PCR primer and 2.5 units PfuTurboCx Hotstart DNA polymerase (Stratagene).
Thermocycling included eight cycles of “touchdown” (Don et al., 1991) at annealing
temperatures from 55°C to 52°C (two cycles at each temperature) followed by 10 cycles
at an annealing temperature of 51°C. Denaturation (94°C), annealing and extension
(72°C) times were 10 s, 30 s and 3 min., respectively. PCR products were cleaned-up by
ultrafiltration followed by preparative electrophoresis on a 2% agarose gel. Typical yields
were between 50 and 100 ng for each library. Gel-purified PCR product (4 ng) were
incubated for 5 min with 1 µl pCR BluntII TOPO vector and cloned by electroporation of
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Escherichia coli TOP10 (Invitrogen). The cloning efficiency was ~2,000 colonies per ng
of PCR product.
Plasmid DNA was isolated by standard protocols, and cloned inserts were
sequenced using 2.7 pmol M13 reverse primer and 2 µl BigDye3.1 mix (Applied
Biosystems) in 10-µl sequencing reactions (25 cycles). Caused by preferential cloning in
one orientation, ~80% of the sequences were the G-poor strand. Most inserts that had
been cloned in the other orientation (C-poor strand) sequenced poorly, with peak-heights
and sequence quality suddenly dropping after 300-400 bases.
Data analysis
In silico digestion of the mouse genome (NCBI Build 33, May 2004) was
performed at BglII sites, followed by selection of fragments ranging from 440 to 640
bases. Cytosines were converted to thymine, with upper/lower case used to differentiate
converted from original thymines. Each strand was converted separately. Sequencing
reads were mapped to the genome by using NCBI BLAST (without query filtering) to
search the database of size-selected and converted BglII fragments. The top BLAST hit
determined the most probable genome location of each read and also permitted
identification of original and converted cytosines over the high-scoring segment pair
length. The repeat content of the in silico reduced representation and the sets of
sequencing reads were compared to that of the whole genome using RepeatMasker
(http://www.repeatmasker.org). Locations of all sequence reads relative to selected
genomic landmarks were determined by comparing fragment coordinates to those of the
RefSeq and Ensembl transcript sets and CpG islands from UCSC.
The expected number of redundant RRBS sequences and the sequence overlap
between two DNA samples were calculated by composite Poisson statistics in 5 bp bins
across the range of insert sizes. Di is the number of BglII fragments in the reference
genome that fall into bin i. Nai is the number of successful sequencing reads from DNA
sample a that fall into bin i. ∑(Nai
2/2Di) double-hits in sample a are expected by random
sampling (Altshuler et al., 2000). The expected number of BglII fragments sequenced at
least once in sample a and in sample b is ∑[(1-e -(Nai/Di))x(1-e -(Nbi/Di))xDi].
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Cre-lox regulated conditional RNA interference in cells and mice
Abstract: The use of RNA interference for studying gene function has become an
essential part of biology. Owing to the dominant nature of RNAi, a major limitation of
this approach is that germ-line transmission can be obtained only for shRNAs targeting
genes whose knock-down is compatible with animal viability and fertility. Moreover,
even for cell-based applications, constitutive knock-down of gene expression by RNAi
can limit the scope of experiments, especially for genes whose inhibition leads to cell
lethality. To overcome these limitations, and to extend the applications of RNAi in
mammalian systems, we have developed a Cre-lox-based approach for the conditional
expression of shRNA. Two different strategies were used to generate mouse embryonic
fibroblasts (MEFs), embryonic stem (ES) cells and transgenic mice in which the
expression of an shRNA is tightly regulated in a Cre-dependent manner. One vector
allows for conditional activation of shRNA expression, whereas the other permits
conditional inactivation of expression of the hairpin RNA. The ability to efficiently
control shRNA expression using these vectors was shown in cell-based experiments by
knocking down p53, nucleophosmin and DNA methyltransferase-1. We also demonstrate
the usefulness of this approach to achieve conditional, tissue-specific RNA interference
in Cre-expressing transgenic mice. Combined with the growing array of Cre expression
strategies, these vectors allow spatial and temporal control of shRNA expression in vivo
and should facilitate functional genetic analysis in mammals.
This part of Chapter 3 has been published:
Ventura A*, Meissner A*, Dillon CP, McManus M, Sharp PA, Van Parijs L, Jaenisch R,
Jacks T. Cre-lox-regulated conditional RNA interference from transgenes. Proc Natl
Acad Sci U S A. 2004 Jul 13; 101 (28):10380-5.
*equal contributing authors
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As outlined in Chapter 1 the rational for generating a system for conditional gene
suppression by RNAi was to investigate conditions, such as global hypomethylation, that
could enhance the reprogramming efficiency. The vectors described here allow in a
simple manner to study the effects of transiently down regulating essential genes. By
subsequently reversing the knockdown and thereby restoring endogenous gene
expression many deleterious effects of longer term suppression can be avoided. In the
following part, I will describe how the vectors were generated and how the effectiveness
of both vectors was tested for a number genes in vitro and in vivo.
Generation of pSico and pSicoR
The U6 promoter has been widely used to drive the expression of shRNAs and a
U6-based lentiviral vector for the generation of transgenic mice has been recently
described (Rubinson et al., 2003). To control shRNA expression in a Cre-dependent
manner, we decided to modify the mouse U6 promoter by inserting a Lox-STOP-Lox
cassette. Similar to other RNA polymerase III promoters, the U6 promoter is extremely
compact, consisting of a tightly spaced TATA box, a proximal sequence element (PSE),
and a distal sequence element (DSE) (Fig. 6a). Mutagenesis experiments have
demonstrated that while the DSE is partially dispensable for transcriptional activity, the
PSE and the TATA box are absolutely required. Moreover, the spacing between the PSE
and the TATA box (17 nt) and between the TATA box and the transcription start site (25
nt) is critical, as even small changes have been shown to severely impair promoter
activity (Paule and White, 2000). A consequence is that to effectively suppress the
activity of the U6 promoter, the Lox-STOP-Lox element must be positioned either
between the PSE and the TATA box or between the TATA box and the transcription start
site. In addition, to reconstitute a functional promoter, after Cre expression, the normal
spacing between PSE, TATA box, and transcription start site must be restored. The latter
consideration precludes the utilization of a classic lox-STOP-lox cassette because, after
Cre-mediated recombination, the residual loxP site (34 nt) would necessarily increase the
PSE-TATA or the TATA-start-site spacing, thus resulting in a non-functional promoter
(See Fig. 7).
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Figure 6: Generation of pSico and pSicoR. a) Schematic representation of the mouse U6 promoter.
The spacing between the DSE, the PSE, the TATAbox, and the transcription start site (1) is
indicated. b) Comparison between the sequence of a loxP site and a TATAlox site (Upper).
Comparison between the sequence of the wild-type mouse U6 promoter and the sequence of the U6
promoter with a TATAlox site replacing the TATA box (Lower). c) The TATAlox can replace the
TATA box in the U6 promoter. Equal amounts of the wild-type U6 promoter and of the TATAlox
U6 promoter (empty or driving the expression of shRNA against the firefly luciferase gene) were
transfected in 293T cells together with reporter plasmids expressing firefly luciferase and renilla
luciferase. Thirty-six hours later, cells were lysed and the ratio between firefly and renilla
luciferase activity was measured. d) A TATAlox-STOPTATAlox cassette in the U6 promoter
efficiently suppresses shRNA expression. Increasing amounts (0–200 ng) of plasmids containing
the indicated version of the U6 promoter were transfected in 293T cells together with reporter
plasmids, and luciferase activity was measured as in c. e) Schematic representation of pSico before
and after Cre-mediated recombination. f) Schematic representation of pSicoR before and after Cre-
mediated recombination. SINLTR, self-inactivating long terminal repeats; Psi, required for viral
RNA packaging; cPPT, central polypurine tract; EGFP: enhanced GFP; WRE, woodchuck
regulatory element.
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Figure 7: a) Schematic representation of the U6 promoters carrying the lox-CMVGFP-lox tested
in panel 6b. The CMV-GFP cassette is not drawn to scale. Test 1 and Test 2 have the lox-STOP-
lox cassette between the DSE and the PSE. In Test 3 the cassette is positioned between the PSE
and the TATA box and finally in Test 4 it is positioned between the TATAbox  and the putative
transcription start site. b) The indicated U6 constructs were assayed as in Figure 6c for their
ability to induce knock-down of the firefly luciferase gene. Note that constructs containing the
lox-stop-lox cassette upstream of the PSE are still capable of efficiently repressing luciferase
activity (Test 1 and Test 2), while the constructs in which the lox-stop-lox cassette is situated
between the PSE and the TATA (Test 3) or between the TATA and the transcription start site
(Test 4), are inactive even in the recombined conformation indicating that in both cases the
residual lox site negatively affects U6 promoter activity.
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To overcome these limitations, we generated a bifunctional lox site (TATAlox), that, in
addition to retaining the ability to undergo Cre-mediated recombination, contains a
functional TATA box in its spacer region (Fig. 6b-d).
As shown in Figure 6, when the TATAlox replaces the TATA box site in the U6
promoter, the spacing between PSE, TATA and transcriptional start site is not altered
(Fig. 6b), and the resulting promoter retains transcriptional activity (Fig. 6c).
To create a conditional U6 promoter, a cytomegalovirus (CMV)-enhanced GFP
stop/reporter cassette was inserted between two TATAlox sites so that after Cre-mediated
recombination the cassette would be excised, generating a functional U6 promoter with a
TATAlox in place of the TATA box (Fig. 6d). A T6 sequence was positioned
immediately upstream of the CMV promoter to serve as a termination signal for RNA
polymerase III. The terminator combined with the inserted CMV-GFP cassette
completely suppressed the activity of the U6 promoter (Figs. 6d and 8c and 8d). To
facilitate the generation of conditional knock-down mice and cell lines, the conditional
U6 cassette was inserted into a self-inactivating lentiviral vector derived from pLL3.7
(Rubinson et al., 2003). The resulting plasmid was named pSico (Fig. 6e).
To allow for conditional inactivation of shRNA expression, we generated a
second vector named pSicoR (Fig. 6f). In pSicoR, the CMV-GFP reporter cassette is
placed downstream of the U6 promoter and does not affect its activity. Two loxP sites in
the same orientation are present in this vector; the first positioned immediately upstream
of the PSE in the U6 promoter, and the second immediately downstream of the GFP-
coding sequence. In contrast to cells infected with pSico, cells infected with pSicoR are
expected to constitutively transcribe the desired shRNA until a Cre-mediated
recombination event leads to the excision of the CMV-GFP cassette and an essential part
of the U6 promoter. Importantly, in both pSico and pSicoR, the CMV-GFP cassette
marks infected cells and loss of GFP expression indicates successful Cre-mediated
recombination.
Cre-regulated RNAi in cells
The ability of pSico and pSicoR vectors to conditional silence endogenous genes
was demonstrated by insertion of a hairpin designed to inhibit expression of the mouse
tumor suppressor gene p53. As a control, the same sequence was cloned into the
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constitutive shRNA vector pLL3.7. In pLL3.7 the CMV-GFP cassette is located
downstream of the U6 promoter and is flanked by loxP sites such that Cre-mediated
recombination is expected to result in loss of GFP expression without affecting shRNA
expression (Rubinson et al., 2003). These three constructs were then used to generate
lentiviruses and infect MEFs. To simplify the detection of p53, MEFs expressing high
basal levels of a transcriptionally inactive point mutant (R270H) p53 allele (K. Olive and
T. Jacks, unpublished work) were used in these experiments. High-efficiency
transduction by all of these vectors was achieved as indicated by uniform GFP expression
in infected cells (Figure 8b and data not shown). As shown in Fig. 8, after superinfection
Figure 8: Cre-regulated knockdown of p53. a) p53R270H/- MEFs infected with the indicated lentiviruses
were sorted for GFP positivity and infected with Ad or Ad-Cre. Four days after infection, genomic DNA
was extracted, and a PCR was performed to amplify the recombined and unrecombined viral DNA. b) The
same cells were analyzed by epifluorescence microscopy to detect GFP. Similar cell density and identical
exposure time was used for all images. c) Fifteen micrograms of totalRNAextracted from the above
indicated MEFs was separated on a 15% denaturing polyacrylamide gel, transferred on a nitrocellulose
filter, and hybridized to a radi-labeled 19mer corresponding to the sense strand of the p53 shRNA. Equal
RNA loading was assessed by ethidium bromide staining of the upper part of the gel (Lower). d) Northern
(Upper) and Western blotting (Lower) showing p53 knock-down in the above indicated cells.
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with a Cre-expressing recombinant adenovirus (Ad-Cre), near complete recombination
with concomitant loss of GFP fluorescence was observed for all vectors. One week after
Cre expression, high levels of the p53-siRNA were detected in cells infected with pSico-
p53 (Fig. 8c), whereas no p53-siRNA was observed in the same cells in the absence of
Cre expression, confirming the complete suppression of U6 promoter activity by the
TATAlox-STOP-TATAlox cassette. The length of the processed RNA (21-24 nt) was
identical in cells infected with pLL3.7-p53, pSico-p53 (after Ad-Cre infection), or
pSicoR-p53 (before Ad-Cre infection), indicating that the presence of the TATAlox in
pSico does not qualitatively affect shRNA production. Finally, infection with Ad-Cre led
to almost complete disappearance of p53-siRNA in pSicoR-p53-infected cells (Fig. 8c).
Consistent with functional p53-siRNA expression by these vectors, Cre-mediated
recombination resulted in a dramatic reduction of both p53 mRNA and protein levels in
pSico-p53-infected cells (Fig. 8d). Conversely, pSicoR-p53 generated a p53 knock-down
that was reversed upon Ad-Cre infection (Fig. 8d). We noticed an unexpected increase in
p53-siRNA and p53 knock-down after Cre expression in cells infected with pLL3.7-p53
(Fig. 8c and 8d, lanes 2 and 3). This increase could reflect promoter interference because
the CMV and the U6 promoters are in close proximity in pLL3.7 before to Cre-mediated
recombination.
As additional proof of concept, we cloned short hairpins directed against the
nucleolar protein Npm and Dnmt1 into pSico and pSicoR. Npm is a putative tumor-
suppressor gene involved in a number of chromosomal translocations associated with
human leukemias and lymphomas, and has been shown to physically and functionally
interact with the tumor suppressors p19ARF and p53 (Bertwistle et al., 2004; Colombo et
al., 2002). Specific, Cre-dependent knock-down of Npm was observed in both MEFs and
ES cell clones infected with pSico-Npm (Figs. 9a and b). The opposite effect, Cre-
dependent reexpression of Npm, was observed in pSicoR-Npm infected MEFs (Figures
9a and 9c).
The characterization of ES cells mutant for Dnmt1 has been reported (Li et al.,
1992), and demonstrated that Dnmt1 is required for genome-wide maintenance of
cytosine methylation. Dnmt1-deficient ES cells are viable and proliferate normally,
despite substantial loss of methylation; however, they die upon differentiation. Whereas
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Figure 9: Cre-regulated knockdown of Npm and Dnmt1. a) Cre-regulated knock-down of Npm. MEFs
were infected with the indicated lentiviruses, and GFP-positive cells were sorted and were superinfected
with empty Ad or Ad-Cre. One week later, whole-cell lysates were separated by SDS PAGE, and were
subjected to Western blotting against Npm and tubulin. b) ES cells carrying a doxycycline-inducible Cre
(C. Beard and R.J., unpublished data) were infected with the indicated lentiviruses. GFP-positive clones
were isolated, passaged two times, and were either left untreated or were incubated with 2 µg/ml
doxycycline for 1 week. Immunoblot analysis was performed as in a. c) Immunofluorescence microscopy
analysis of MEFs infected with pSico-Npm, pSicoR-Npm or pSico-CD8. After lentiviral infection GFP-
positive MEFs were sorted and superinfected with empty Adenovirus or Ad-Cre. One week later cells
were co-plated on glass coverslips, fixed and decorated with anti Npm antibody (red). Nuclei were stained
with DAPI. d) Cre-regulated knock-down of Dnmt1 affects cytosine methylation. Methylation analysis of
minor satellite DNA. ES cells carrying a doxycycline-inducible Cre transgene were infected with the
indicated lentiviruses. Single GFP-positive clones were isolated, expanded, and passaged five times
before being either mock-treated or incubated with 2 µg/ml doxycycline. After five more passages, the
genomic DNA was extracted and digested with the indicated enzymes and subjected to Southern blot
analysis. e) As in d, but the genomic DNA was treated with sodium bisulfite, subjected to PCR to amplify
the indicated imprinted regions, and digested with BstUI.
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re-expression of the Dnmt1 cDNA in these cells leads to methylation of bulk genomic
DNA and nonimprinted genes, the methylation pattern of imprinted loci cannot be
restored without germ-line passage (Tucker et al., 1996). We tested whether we could
recapitulate the phenotype observed in Dnmt1-deficient ES cells by using pSico-Dnmt1
and pSicoR-Dnmt1. As shown in Figure 9, pSico-Dnmt1-infected ES cells underwent
significant loss of CpG methylation of minor satellites (Fig. 9d) and of two imprinted
genes tested (Fig. 9e) upon Cre induction. Importantly, the reacquisition of DNA
methylation at minor satellites sequences, but not at imprinted loci in pSicoR-Dnmt1
after Cre-mediated recombination, confirms previous results obtained with reexpression
of Dnmt1 (Tucker et al., 1996). These results further illustrate the potential for
application of the pSicoR vector in vitro and in vivo to perform “rescue” experiments.
Conditional RNAi in mice
One motivation for incorporating a conditional U6 cassette into a lentiviral vector
was to rapidly generate conditional knock-down mice. To demonstrate this application
directly, ES cells were infected with pSico-CD8 (Fig. 10a), which was designed to inhibit
expression of the T lymphocyte cell surface marker CD8 (Rubinson et al., 2003). Three
pSico-CD8 ES clones were used to generate chimeric mice, and transmission of the
pSico-CD8 transgene to the progeny was observed for two of them. All transgenic mice
were easily identified by macroscopic GFP visualization (Fig. 10b), although we
observed some variability in the extent and distribution of GFP expression among
littermates. Importantly, all transgenic mice produced normal amounts of CD4+ and CD8+
lymphocytes and were apparently normal and fertile, indicating that the presence of the
nonexpressing pSico-CD8 transgene before Cre activation did not affect CD8 expression
and was compatible with normal mouse development. To achieve either global or tissue-
specific activation of the CD8 shRNA, pSico-CD8 chimeras were crossed to Msx2-Cre or
Lck-Cre transgenic mice that express Cre in the oocyte (Gaudet et al., 2004; Sun et al.,
2000), or under the control of a T cell-specific promoter (Hennet et al., 1995),
respectively. Flourescence-activated cell sorter analysis demonstrated that pSico-
CD8;Lck-Cre and pSico-CD8;Msx2-Cre mice had a specific reduction in splenic CD8+,
but not CD4+ T lymphocytes as compared to controls (Fig. 10c). As predicted, the pSico-
CD8;Msx2-Cre progeny showed complete recombination of
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Figure 10: C o n d i t i o n a l
knockdown of CD8 in
transgenic mice. a)  ES cells
infected with pSico-CD8
visualized with an inverted
fluorescence microscope. b) A
litter of newborns derived from
a cross between a pSico-CD8
chimera and an Lck-Cre female.
Three pups present bright GFP
fluorescence, indicating germ-
line transmission of the pSico-
CD8 transgene. c) Knock-down
of CD8 in the spleen of Msx2-
Cre   pSico-CD8 and Lck-Cre
pSico-CD8 mice. Chimeras
from pSico-CD8-infected ES
cells were crossed to Msx2-Cre
or Lck-Cre animals. The
resulting mice were genotyped
for the presence of Cre and
pSico. Splenocytes from 1- to
3-week old mice with the
indicated genotypes were
harvested, stained for CD3,
CD4, and CD8 expression, and
analyzed by flow cytometry.
Only CD3 cells were plotted.
One representative example of
littermates for each cross is
shown. d)  PCR detection of
Cre-mediated recombination of
pSico-CD8 in genomic DNA
extracted from the tail (A) or the
thymus (B ) of mice with the
indicated genotypes.
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the pSicoCD8 transgene and lacked detectable GFP expression, while in the pSico-
CD8;LckCre mice recombination was detected in the thymus but not in other tissues (Fig.
10d and data not shown). Transgenic mice derived from two different ES clones gave
similar results.
Tetraploid blastocyst complementation represents a faster alternative to diploid
blastocyst injection because it allows the generation of entirely ES-derived mice without
passage through chimeras (Eggan et al., 2001a; Tanaka et al., 2001). In principle, this
technology applied to pSico-infected ES cells would allow the generation of conditional
Figure 11: Generation of conditional knockdown embryos by tetraploid complementation. a) A postnatal
day 14.5 embryo derived by tetraploid complementation using the pSico-p53 #1 ES clone. The area
enclosed by the dashed line corresponds to the non-ES cell-derived placenta. b) PCR detection of
recombination in MEFs derived from the indicated embryos. Genomic DNA was extracted 4 days after
Ad or Ad-Cre infection and subjected to PCR. c) Histogram overlays showing loss of GFP expression in
MEFs derived from pSico-p53#1 (Upper) and pSico-p53#3 (Lower) embryos 4 days after Ad-Cre (green
plot) or Ad empty (purple filled plot) infection. Control, GFP-negative MEFs (red plot) are included as
reference. d) Cell cycle profile of MEFs derived from embryos with the indicated genotypes infected with
Adeno empty or AdenoCre and either mock treated or treated with 1µg/ml doxorubicin for 18 hours. e)
MEFs derved from the indicated tetraploid complementation pSico-p53 embryos, or from wild-type
embryos, were treated with doxorubicin for 18 h and subjected to Western blot against p53 and beta-
tubulin.
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knock-down mice in ~5-6 weeks (1 week for cloning the shRNA, 1-2 weeks for ES cells
infection and clone selection, and ~2 weeks for tetraploid blastocyst injection and
gestation). To test this protocol directly, ES cells were infected with pSico-p53 and two
different clones, pSico-p53#1 and pSico-p53#3, were injected into tetraploid blastocysts.
As a rapid way to assess the inducibility of the p53 shRNA in ES cell-derived animals,
midgestation embryos were recovered from two recipients females. Two apparently
normal, GFP positive embryos were recovered; one each from ES clone pSico-p53 #1
and pSico-p53 #3 (Fig. 11a and data not shown). MEFs generated from these embryos
were passaged once and infected with Ad or Ad-Cre. As expected, Cre expression
induced significant recombination and loss of GFP expression (Figs. 11b and c).
Importantly, in Ad-Cre-infected cells, p53 induction and cell-cycle arrest after
doxorubicin treatment were significantly inhibited compared to Ad-infected control cells
(Figs. 11d and e).
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Generation of nuclear transfer-derived pluripotent ES cells from cloned
Cdx2-deficient blastocysts
Abstract: The derivation of embryonic stem (ES) cells by nuclear transfer holds great
promise for research and therapy but involves the destruction of cloned human
blastocysts. Proof of principle experiments have shown that “customized” ES cells
derived by nuclear transfer (NT-ESCs) can be used to correct immuno-deficiency in mice
(Rideout et al., 2002). Altered Nuclear Transfer (ANT) has been proposed as a variation
of nuclear transfer because it would create abnormal nuclear transfer blastocysts that are
inherently unable to implant into the uterus but would be capable of generating
customized ES cells (Hurlbut, 2005). To assess the experimental validity of this concept
we have used nuclear transfer to derive mouse blastocysts from donor fibroblasts that
carried a short hairpin RNA construct targeting Cdx2 (pSicoR-Cdx22Lox). The conditional
lentivirus-based vector, pSicoR, was described extensively in the previous part. Cloned
blastocysts were morphologically abnormal, lacked functional trophoblast and failed to
implant into the uterus. However, they efficiently generated pluripotent embryonic stem
cells when explanted into culture.
This part of chapter 3 has been published:
Meissner A, and Jaenisch R. Generation of nuclear transfer-derived pluripotent ES cells
from cloned Cdx2-deficient blastocysts. Nature. 2006 Jan 12; 439 (7073): 212-5.
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The second application of our conditional gene knockdown approach using RNAi
was aimed at testing the notion that development of an embryo derived by SCNT might
be restricted by temporarily inactivating Cdx2, yet the same embryo might be fully
competent for extracting embryonic stem cell lines useful for therapeutic purposes.
Altered nuclear transfer (ANT)
Survival of the normal embryo beyond implantation depends on the formation of
the trophectoderm lineage, the extra-embryonic lineage that forms the fetal-maternal
interface within the placenta. The second embryonic lineage that forms, the inner cell
mass (ICM), gives rise to all subsequent lineages in the embryo proper, and it is the ICM
that, upon explanting in culture, gives rise to ES cells. The “altered nuclear transfer”
(ANT) concept (Hurlbut, 2005) is based on the premise that the inactivation of a gene
crucial for trophectoderm development will eliminate the potential to form the fetal-
maternal interface, but will spare the ICM lineage. By genetically altering a somatic
donor cell before to nuclear transfer, one could generate cloned blastocysts that have no
potential to develop beyond the blastocyst stage because no placenta could be formed.
However, such cloned blastocysts could generate NT-ESCs derived from the ICM.
In this study we have performed a proof-of-principle experiment in mice to test
the validity of the ANT approach and chose Cdx2 as a candidate gene, as this gene
encodes the earliest-known trophectoderm-specific transcription factor that is activated in
the 8-cell embryo and is essential for establishment and function of the trophectoderm
lineage (Chawengsaksophak et al., 2004; Strumpf et al., 2005). Cdx2-deficient
blastocysts fail to maintain a blastocoel, lack epithelial integrity, dysregulate the ICM-
specific transcription factors Oct-4 and Nanog, and show increased cell death (Strumpf et
al., 2005). Importantly, Cdx2-deficient blastocysts are able to form an ICM and generate
ES cells when explanted in tissue culture (Chawengsaksophak et al., 2004; Strumpf et al.,
2005).
Generation of Cdx2 deficient NT-ES cells
We selected for functional short hairpin (sh)RNAs against Cdx2 as described in
Figures 12 and 13. The experimental scheme, outlined in Figure 14a, involved the
introduction of a conditional Cdx2 shRNA lentiviral vector (Fig. 14b) into primary tail-
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tip fibroblasts from neonatal F1 mice (C57BL/6x129/SvJae). Green fluorescent protein
(GFP)-positive
Figure 12: Selection of functional shRNAs. To select functional shRNAs against Cdx2, several
Cdx2 shRNA target sequences were cloned into the 3’UTR of a DsRed reporter construct. Next
transient co-transfections (293 cells) of the various DsRed-Cdx2 plasmids and the respective
knockdown constructs were used to determine the potency of each hairpin by fluorescence
microscopy and fluorescence activated cell sorting (FACS) analysis a) DNA sequence of the Cdx2
shRNA used. b) The sense strand sequence was cloned into the 3’UTR of a DsRed reporter gene
containing plasmid (Clontech). c) DsRed-Cdx2 was mixed with FUGENE (Roche) and split into two.
To the first well a pSicoR-CD8 (control, no target sequence present for the CD8 shRNA) was added
and to the second well the pSicoR-Cdx2 vector (knockdown, DsRed contains the target sequence).
Two different versions of the pSicoR vector were used, one containing a pgk-puro selection gene (d
and e) and the other one a CMV-EGFP cassette (f and g). d-g) The knockdown efficiency was
determined 24-48h post infection by fluorescence microscopy (images shown were taken with
identical exposure time) and fluorescence activated cell sorting (FACS) analysis (data not shown).
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Figure 13: Knockdown of
endogenous Cdx2. The knockdown
efficiency against endogenous Cdx2
was demonstrated using ZHBTc4
ES cells that upon downregulation
of Oct-4 (doxycycline dependent)
differentiate into trophectoderm
with concomitant upregulation of
Cdx2 expression. Semi-quantitative
RT-PCR was used with 25, 30 and
35 amplification cycles for Cdx2.
Cdx2 was readily detectable after
27h in the uninfected control cells.
In the presence of the shRNA no
Cdx2 was detected even after
prolonged repression of Oct-4, which was confirmed by immunohistochemistry (data not shown). In the
control cells, but not in the Cdx2 knockdown cells we detected a faint Cdx2 signal after 35 cycles of
amplification. The absence of the signal in the knockdown cells at 0h suggests that it might be real and
could originate from a small fraction of the ES cells that were differentiated. (ZHBTc4: Niwa et al., 2000)
Figure 14: Derivation of NT-ESCs from Cdx2-deficient blastocysts. a) Primary tail-tip fibroblasts were
infected with a conditional lentiviral RNA interference (RNAi) construct targeting Cdx2 before nuclear
transfer (NT). Blastocysts deficient for Cdx2 were morphologically abnormal and unable to implant but
gave rise to NT-ESCs. After initial expansion of the Cdx2 knockdown NT-ESCs (Cdx22Lox) we used
transient Cre expression to generate subclones (Cdx21Lox) with a deleted hairpin. To test the potency of ES
lines before and after ‘loop-out’ we used teratoma formation, diploid and tetraploid blastocyst injections
as well as nuclear transfer. b) The conditional RNAi system (pSicoR) has been described above. The
shRNA, which targets nucleotides 1890–1908 located in the 30 UTR of Cdx2, was cloned into the
conditional RNAi vector generating pSicoR-Cdx22Lox. This vector carries the Cdx2 shRNA construct and
an enhanced green fluorescence protein (EGFP) gene flanked by two LoxP sites (2Lox), which allows for
Cre-mediated deletion of the shRNA and the EGFP sequences.
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Cdx22Lox tail-tip fibroblasts were selected and used as donors for nuclear transfer. Cdx2-
deficient blastocysts derived from the manipulated donor cells were tested for their
potential to implant into the uterus and to generate pluripotent ES cells.
Of a total of 526 reconstructed oocytes, 350 formed pronuclei, of which 61
cleaved and developed into nuclear transfer morula/blastocysts. Cdx2 knockdown nuclear
transfer embryos showed no delay in developing to the early blastocyst stage compared to
Figure 15: Cdx2-deficient blastocysts and ES cell derivation. a) Cdx2 immunostaining of day 3.5–4.5
wild-type and nuclear transfer blastocysts. The following donor cells were used for the nuclear transfer
(from second column, left to right): Cdx22Lox tail-tip, Cdx22Lox ES cells, and Cdx21Lox ES cells. b) A
typical Cdx22Lox tail-tip nuclear transfer blastocyst is shown 84 h after activation of the reconstructed
oocytes. Cdx2-deficient blastocysts initially cavitated but failed to maintain the blastocoel and collapsed.
Below, an expanded nuclear transfer blastocyst derived from control cells is shown. c) RT–PCR analysis
of normal and Cdx2-deficient nuclear transfer preimplantation morula/blastocysts. Four 4-cell embryos
were pooled andRNA was extracted for reverse transcription. All other samples were prepared from single
morulae or blastocysts. Tail-tip fibroblasts (lane 6) express neither Cdx2 nor Oct-4. Trophectoderm stem
(TS) cells (lane 7) express Cdx2, but no Oct-4. A faint Cdx2-specific band, such as that seen in the
blastocyst containing the shRNA construct targeting Cdx2 shown in the figure, was detected in less than
half of the tested embryos; most gave no signal in this test. d) Derivation of ES cells from Cdx2-deficient
blastocysts. A Cdx22Lox tail-tip nuclear transfer-derived blastocyst with its initial outgrowth after 72 h
(left) and a wild-type blastocyst (right) with its initial outgrowth are shown.
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nuclear transfer embryos expressing a shRNA targeting CD8 ((Ventura et al., 2004); data
not shown). Figure 15a shows that GFP-positive Cdx22Lox nuclear transfer blastocysts did
not express Cdx2 as assessed by immunohistochemistry, in contrast to wild-type
blastocysts (column 1 and 2, Fig. 15a). Figure 15b shows that, when compared to control
nuclear transfer blastocysts, Cdx22Lox nuclear transfer blastocysts were morphologically
abnormal and failed to maintain a blastocoel cavity during in vitro cultivation, similar to
previous results with Cdx2 knockout blastocysts (Strumpf et al., 2005). Using semi-
quantitative polymerase chain reaction with reverse transcription (RT-PCR), we
confirmed the deficiency of Cdx2 expression in Cdx22Lox nuclear transfer blastocysts,
whereas control morulae and blastocysts showed robust Cdx2 expression (Fig. 15c).
Developmental potential of Cdx22Lox NT-ES cells
To assess whether Cdx2 deficiency interfered with postimplantation development,
Cdx22Lox nuclear transfer morulae/blastocysts were transferred into the uteri of pseudo-
pregnant females. The uteri were removed at embryonic day E6.5 and examined for sites
of implantation. Figure 16a shows no implantations in the uterus from a foster mother
transplanted with five Cdx22Lox nuclear transfer blastocysts, in contrast to a uterus
transplanted with five nuclear transfer control blastocysts that resulted in successful
implantations (Fig. 16b). As summarized in Table 2, none of the Cdx22Lox nuclear transfer
blastocysts formed visible implantation sites (0 out of 40), in contrast to control nuclear
transfer blastocysts that were derived from fibroblasts carrying the CD8 control shRNA
(6 out of 15). In addition, no evidence for delayed implantation was obtained, as we
failed to detect implantation sites at E7 or E8 in females transplanted with a total of 18
Cdx2 knockdown nuclear transfer embryos (data not shown). These results demonstrate
that nuclear transfer from donor fibroblasts carrying the pSicoR-Cdx22Lox virus resulted
in morphologically abnormal Cdx2-deficient nuclear transfer blastocysts that failed to
implant upon transfer into foster mothers.
To investigate whether Cdx2-deficient blastocysts can generate ES cells upon
explantation in culture, nuclear transfer Cdx22Lox blastocysts were transferred onto feeder
cells. While control nuclear transfer blastocysts formed trophoblastic outgrowths
characteristic of the trophectoderm lineage, the Cdx22Lox nuclear transfer blastocysts
failed to generate any trophoblast cells (Fig. 15d). Consistent with previous observations
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Figure 16: Cdx2-deficient cells maintain developmental potential but are unable to implant after nuclear
transfer. a-b) In each example shown, five nuclear transfer blastocysts were transferred at day 3.5 into the
uterus of a day 2.5 pseudo-pregnant female. a) Cdx2-deficient blastocysts fail to implant. A representative
uterus isolated at day 6.5 is shown. No deciduae were detectable from transplanted Cdx2-deficient
blastocysts. b) Control nuclear transfer blastocysts showed normal implantation sites at day 6.5. c) Bright-
field image of a postnatal Cdx22Lox ES chimaera. d) GFP signal indicates a contribution from Cdx22Lox ES
cells. e–g) Histological sections and anti-GFP staining from a newborn Cdx22Lox chimaera. There was a
contribution to the liver (endoderm; e) and muscle (mesoderm; f) but not to the intestine (g). h) Anti-Cdx2
staining of the intestine shown in g. i) Coat colour contribution of Cdx22Lox ES cells. Recipient blastocysts
have a C57BL/6 x DBA/2 F1 background and the Cdx22Lox ES cells a C57BL/6 x 129SvJae background.
The presence of agouti (129/SvJae) fur indicates donor cell contribution. A litter with one wild type (black
mouse below the top agouti), two low-contribution (middle) and two high-contribution chimaeras are
shown.
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(Chawengsaksophak et al., 2004; Strumpf et al., 2005), Cdx2-deficient blastocysts
generated ICM outgrowths that grew into stable, GFP-positive nuclear transfer Cdx22Lox
ES cell lines with an efficiency that was comparable to that of nuclear transfer blastocysts
derived from wild-type fibroblasts (14% of explanted blastocysts). As criterion for
pluripotency, we tested the ability of the nuclear transfer Cdx22Lox ES cell lines to form
chimeras when injected into diploid blastocysts. The GFP-labeled cells contributed
extensively to neonatal chimeras (Figs. 16c, d) and formed high-grade postnatal chimeras
(Fig. 16i, summarized in Table 3) with high contributions to most tissues (Fig. 16e, f),
with the notable exception of the intestine (Fig. 16g), which was entirely composed of
Cdx2-positive cells derived from the host blastocyst (Fig. 16h). This is in agreement with
previous reports, as it has been shown that Cdx2 is required for normal development of
the gastro-intestinal tract (Chawengsaksophak et al., 1997). We further explored the
developmental potency of the NT-ESCs using tetraploid complementation, which
Table 3: Developmental potential of ES cells deficient (Cdx22Lox) or proficient (Cdx21Lox)
for Cdx2 expression.
Table 2: Survival of clones to blastocyst and post-implantation stage after nuclear transfer
from different donor cells.
Shown are the number of reconstructed oocytes with pseudo-pronuclei after 5–6 h of
activation. Morula/blastocyst transfers were done on day 3.5. pSicoR-CD82Lox fibroblasts
carry a shRNA against CD8 (see above).
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represents the most stringent test for pluripotency, as the resulting “ES mice” are entirely
composed of cells derived from the injected ES cells (Eggan et al., 2001b). Consistent
with previous results (Chawengsaksophak et al., 2004), transfer of the Cdx22Lox ES cells
resulted in no live embryos at E14 (Table 3). These data indicate that nuclear transfer
using pSicoR-Cdx22Lox fibroblasts generates abnormal blastocysts that are inherently
unable to implant and grow into a fetus but are able to generate pluripotent ES cells that
have a diminished developmental potency as compared to wild-type ES cells.
Restoring Cdx2 function
To assess whether NT-ESCs derived from Cdx2-deficient blastocysts could have
the same pluripotency as wild-type ES cells, we investigated whether the block to normal
developmental potential could be relieved by reversing the effects of the Cdx2 gene
knock-down. Normal Cdx2 gene function was restored in Cdx22Lox ES cells by transient
transfection of a Cre plasmid, resulting in the deletion of the Cdx2 shRNA and EGFP
marker gene (Cdx22Lox to Cdx21Lox; compare Fig. 14b), and rendering the cells Cdx2
competent and GFP negative. Nuclear transfer from Cdx21Lox donor cells generated GFP
negative normal appearing nuclear transfer blastocysts that expressed wild type levels of
Cdx2, as shown by immunostaining (Fig. 15a, right column) and RT-PCR (Fig. 15c, lane
5). To test whether deletion of the shRNA would restore pluripotency, the Cdx21Lox ES
cells were injected into tetraploid blastocysts. As shown in Table 2, Cdx21Lox ES cells
efficiently generated ES mice in contrast to the Cdx22Lox ES cells that were unable to give
rise to ES mice. These results show that the deletion of the Cdx2 shRNA sequences
creates ES cells that can generate all somatic tissues including normal intestinal cells,
which cannot be derived from the Cdx22Lox parental ES cells (compare Fig. 16g, h).
Finally, to test whether totipotency of Cdx21Lox ES cell nuclei was recovered, we
transplanted Cdx21Lox blastocysts derived by nuclear transfer using Cdx21Lox donor ES
cells into pseudo-pregnant foster mothers. As summarized in Table 2, normal-sized
implants were detected at E6.5. These results confirm that Cdx2 deficiency was
responsible for the failure of clones to generate functional blastocysts and exclude other
genetic alterations acquired during in vitro manipulation of the cells in the characteristic
block to implantation. Most importantly, our data demonstrate that ES cells competent to
generate all lineages can be derived from abnormal nuclear transfer blastocysts.
Chapter 3- Results RRBS
66
Reduced Representation Bisulfite Sequencing for comparative high-
resolution DNA methylation analysis
Abstract: To improve the study of epigenetic differences between cell types more global
approaches for analyzing epigenetic modifications are required. We have developed a
large-scale random approach termed reduced representation bisulfite sequencing (RRBS)
for analyzing and comparing genomic methylation patterns. BglII restriction fragments
were size-selected to 500-600 bp, equipped with adapters, treated with bisulfite, PCR
amplified, cloned and sequenced. We constructed RRBS libraries from murine ES cells
and from ES cells lacking DNA methyltransferases Dnmt3a and 3b and with knocked-
down (kd) levels of Dnmt1 (Dnmt[1kd,3a-/-,3b-/-]). Sequencing of 960 RRBS clones from
Dnmt[1kd,3a-/-,3b-/-] cells generated 343 kb of non-redundant bisulfite sequence covering
66,212 cytosines in the genome. All but 38 cytosines had been converted to uracil
indicating a conversion rate of >99.9%. Of the remaining cytosines 35 were found in
CpG and 3 in CpT dinucleotides. Non-CpG methylation was >250-fold reduced
compared to wild-type ES cells, consistent with a role for Dnmt3a and/or Dnmt3b in CpA
and CpT methylation. Closer inspection revealed neither a consensus sequence around
the methylated sites nor evidence for clustering of residual methylation in the genome.
Our findings indicate random loss rather than specific maintenance of methylation in
Dnmt[1kd,3a-/-,3b-/-] cells. Near-complete bisulfite conversion and largely unbiased
representation of RRBS libraries suggest that random shotgun bisulfite sequencing can be
scaled to a genome-wide approach.
This part of Chapter 3 has been published:
Meissner A*, Gnirke A*, Ramsahoye B, Bell G, Lander ES, Jaenisch R. Reduced
Representation Bisulfite Sequencing for comparative high-resolution DNA methylation
analysis. Nucleic Acid Research. 2005 Oct 13; 33 (18): 5868-77.
* equal contributing authors
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Another approach in studying epigenetic reprogramming is to determine the
epigenetic differences between different cellular states, and to further elucidate what
defines the nature of “stemness” within a stem cell. DNA methylation is probably the
best studied epigenetic modification that determines patterns of gene expression within a
cell. In order to better define the epigenome of different cell types, we have developed an
approach for large-scale high resolution DNA methylation analysis.
Reduced representation bisulfite sequencing
RRBS is analogous to the reduced representation shotgun sequencing (RRS) used
for single nucleotide polymorphism (SNP) discovery (Altshuler et al., 2000). The method
is based on size selection of restriction fragments to generate a “reduced representation”
of the genome of a strain, tissue or cell type.
For this study, we digested genomic DNA with BglII and purified fragments
between 500 and 600 bp in size on an agarose gel. Based on the available mouse genome
sequence, BglII digestion is expected to generate 21,939 BglII fragments in this size
range comprising ~12 Mb (0.5%) of the genome. Size-selected BglII fragments were
equipped with end adapters, denatured and treated with bisulfite to convert all
unmethylated cytosines to uracil. Bisulfite-converted DNA remains single-stranded as the
two strands are no longer complementary. Primers specific for the converted adapter
sequence and a proofreading thermostable DNA polymerase were used to synthesize the
second strand and to PCR amplify the bisulfite-converted material. Blunt-end PCR
products were cloned in a plasmid vector and sequenced (Fig. 17).
For analysis of the bisulfite sequences and to identify the corresponding genomic
sequence we searched RRBS reads against a reduced representation database of the
mouse genome that contained both strands of BglII fragments that had been size-selected
and bisulfite-converted in silico. When aligned to the original genome sequence, a 5-
methylcytosine is thus displayed as a matching C in the bisulfite sequence, and C to T
transitions indicate unmethylated cytosines.
Even though bisulfite sequencing is a widespread technique, some concerns
persist. Since bisulfite converts single-stranded but not double-stranded DNA, incomplete
denaturation or reannealing leads to incomplete conversion. This complicates the data
analysis, as it is not always possible to determine whether an unconverted cytosine
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represents bona fide methylation or an experimental artifact. Another potential problem is
depurination, strand breakage and DNA degradation caused by the harsh reaction
conditions, which lower the yield of full-length BglII fragments significantly. It has been
estimated that >90% of the input DNA is lost due to DNA degradation during the first
hour of a bisulfite reaction (Grunau et al., 2001). However, to maximize the conversion
rate, the reaction is usually carried out overnight, necessitating extensive PCR
amplification before cloning or sequencing to compensate for the inevitable loss of DNA.
Moreover, since most proofreading enzymes stall at uracil residues in the template strand,
non-proofreading Taq polymerase is usually prescribed for second-strand synthesis and
PCR amplification which can lead to PCR-induced sequencing errors.
These limitations are less worrisome for single-copy loci, but could be significant
in a genome-wide setting, where no preselection against fast-reannealing repetitive
sequences is made and where amplification bias and skewed sequence representation
creates serious sampling problems. Indeed, our preliminary attempts were plagued by
DNA degradation, incomplete conversion and poor efficiency of PCR amplification, most
Figure 17: Reduced representation
bisulfite sequencing. Genomic DNA
is digested to completion using a
restriction enzyme (here BglII).
After size-selection an adapter is
added. The DNA is denatured, and
unmethylated cytosines are bisulfite-
converted to uracil. The two
resulting C-poor strands are no
longer complementary to each other.
Primers specific for the converted
adapter sequence are used to fill-in
the second (G-poor) strand and for
PCR amplification. PCR products
are cloned and sequenced.
Sequences generated from RRBS
libraries are projected onto the
genome by searching against a
reduced representation database of
BglII fragments that had been size-
selected and bisulfite-converted in
silico.
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likely caused by the re-annealing of repetitive sequences including the common adapter
sequence at the ends of each DNA molecule. Moreover, certain sequences were clearly
overrepresented in the resulting libraries indicating amplification bias during the PCR.
These initial problems were largely remedied by performing the bisulfite reaction in the
presence of urea as suggested by Paulin et al. (Paulin et al., 1998) and by fine-tuning
experimental parameters such as DNA concentration, time and temperature of the
bisulfite reaction, and number of PCR cycles for the double-strand rescue and
amplification by a proofreading thermostable DNA polymerase engineered to accept
uracil in the template strand (Fogg et al., 2002).
To test if our optimized protocol was sufficient to achieve complete genome-wide
bisulfite conversion without compromising library complexity and representation, we
wished to construct and sequence RRBS libraries from genomic DNA that was largely
free of methylation. To this end we generated ES cells deficient in all three major DNA
methyltransferases.
ES cells deficient for Dnmt1, Dnmt3a and Dnmt3b
We combined knockouts for the de novo Dnmts (Dnmt3a and Dnmt3b) with
RNAi-induced knockdown of Dnmt1 (Fig. 18a) using a lentivirus-based system for stable
short hairpin RNA (shRNA) expression (Ventura et al., 2004). The Dnmt1 knockdown
resulted in a significant albeit not complete loss of Dnmt1 protein compared to the
Dnmt[3a-/-,3b-/-] control cells (Fig. 18b).
To determine whether the decrease in Dnmt1 levels led to efficient demethylation,
we analyzed the methylation status of minor satellite repeats and IAP elements in a
number of control and knockdown ES cell lines by MSRE analysis. Significant repeat
demethylation was observed when Dnmt1 was knocked down, and the methylation levels
in the Dnmt[1kd,3a-/-,3b-/-] ES cells closely resembled the digest of genomic DNA with
MspI which cuts irrespective of the methylation status (Fig. 19a and b). Loss of
methylation at these repeat elements appears to be primarily caused by the lack of Dnmt1
and largely independent of the de novo Dnmts at these early passages. Using a COBRA
assay (Eads and Laird, 2002) we observed loss of imprinting at four imprinted genes
following Dnmt1 knockdown as compared with the controls (Fig. 19c). Taken together,
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these experiments showed that Dnmt1 knockdown resulted in significant loss of
methylation at specific genes and repeat elements.
To better quantify these results, we used NNA, which allowed to determine the
global amounts of CpG methylation in wild-type and mutant ES cells. We detected ~2%
residual CpG methylation in the Dnmt[1kd,3a-/-,3b-/-] cells compared to 22% in the Dnmt1
null ES cells and 75% in wild-type ES cells (Fig. 19d). Dnmt3b heterozygous and
homozygous ES cells displayed wild-type methylation levels in the presence of Dnmt1
and showed similar loss of methylation within six passages of Dnmt1 knockdown (Fig.
19d and data not shown) confirming the potency of the shRNA.
To test the RRBS approach and to determine whether specific sequences were
retaining methylation we generated and sequenced BglII RRBS libraries from wild-type
and Dnmt-deficient ES cells.
Figure 18: Generation of Dnmt1, Dnmt3a and Dnmt3b deficient ES cells. a) Dnmt3a/3b homozygous
double knockout ES cells have been described previously (Okano et al., 1999). The knockdown virus is
expressing a Dnmt1 shRNA, whereas the control is not. The infection was termed Passage 0. After the
infection ES cells were passaged four times on feeders followed by two additional passages under feeder-
free conditions (Passage 6). Number of viral integrations were determined by Southern blotting and clones
with single integration were selected (data not shown). b) Western blot analysis. The status of the different
Dnmts is indicated above. The knockdown ES cells showed a significant reduction in Dnmt1 levels
compared with their sister clone. c/c is a previously reported Dnmt1 null ES line (Lei et al., 1996).
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Figure 19: Methylation status of the Dnmt-deficient ES cells. All knockdown and control
ES cells were analyzed at Passage 6 after infection. a) Minor satellite repeat methylation.
HpaII digests of genomic DNA were hybridized to minor satellite probe pMR150. MspI is
an isoschizomere of HpaII and cuts irrespective of the methylation status (i.e. appearance of
a ladder in HpaII lane indicates loss of methylation). The status of the different Dnmts is
shown above the Southern blot. All knockdown and control ES cell lines were generated as
described in Figure 18. Each knockdown line contains a single lentiviral integration (data
not shown). b) IAP methylation. HpaII-digested genomicDNAwas hybridized to an IAP
probe. c) COBRA analysis for imprinted genes. Genomic DNA was bisulfite treated and
after PCR amplification of H19, Snrpn, Peg1 and Peg3 a restriction digest was performed to
analyze the methylation status of the differentially methylated regions (U=unmethylated,
M=methylated). The second (smaller) fragment of the methylated and digest product is not
shown. d) Total mCpG quantification by NNA. The spots corresponding to CpG and
mCpGare indicated in the upper left panel. The per cent mCpG/(CpG+mCpG) are displayed
in each panel (estimated error 5%).
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Sequencing of RRBS libraries
In preliminary experiments we noticed that sequencing RRBS clones with reverse
primer had a significantly higher success rate and produced longer reads on average than
sequencing with forward primer. We therefore sequenced the RRBS clones single-pass
using reverse primer. Only clones with high-quality sequence across the entire length of
the insert were used for the final methylation analysis. Table 4 summarizes the
sequencing statistics from 960 RRBS clones from Dnmt-deficient cells and 192 clones
from wild-type ES cells.
Although blunt-ended PCR products can insert in either orientation into the
cloning vector, only a minority had inserts in the orientation that resulted in the C-poor
sequence, i.e. the strand that has been modified by bisulfite (153 out of 876 RRBS reads
from the Dnmt[1kd,3a-/-,3b-/-] library). The vast majority of the clones produced the
Table 4: Sequencing and methylation statistics
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complementary G-poor reads. Notably, the sequence quality was also significantly
different for the two orientations. Almost all G-poor reads were high-quality across the
entire insert whereas peak heights and quality of many C-poor reads dropped after a few
hundred bases, leaving relatively few complete C-poor sequences for the methylation
analysis. Preferential cloning in one orientation and high drop-out rate for C-poor strands
were more pronounced in the Dnmt[1kd,3a-/-,3b-/-] library which has an extremely
asymmetric base distribution. Of the sequenced inserts 96% from this library consisted
solely of three bases, i.e., either A, G and T or A, C and T due to complete absence of
methylated cytosine in the corresponding genome loci. Directional cloning and
sequencing bias has been observed before with bisulfite-treated DNA (Grunau et al.,
2001) and is therefore not a RRBS specific phenomenon.
Of the complete RRBS reads from Dnmt[1kd,3a-/-,3b-/-] cells (89%) found a near-
perfect match in the reduced representation reference-sequence database and could be
placed with high confidence on the mouse genome. The rate of genome alignments for
sequences from wild-type ES was slightly higher (94%). Overall, the success rate of full-
length, mapped bisulfite sequence was 72% of all clones picked. A schematic of the
distribution of RRBS sequences along the mouse chromosomes is available in Figures 20
and 21. In addition we have developed a genome browser that allows a more
comprehensive view of the genomic environment of the RRBS libraries and the data
generated (for a sample screenshot see Fig. 22).
Fifty-six loci were hit by more than one RRBS sequence from the Dnmt[1kd,3a-/-
,3b-/-] library. Ten of these potentially represent sequences that occur more than once in
the genome. The remaining 46 appear to be unique loci that have indeed been cloned and
sequenced twice. This is more than the 23 double-hits expected by random sampling of
an ideal library, possibly indicating a slight cloning or sequencing bias. Consistent with
random cloning, the much smaller number of wild-type RRBS sequences produced only
one double-hit. Eleven fragments were sequenced in both cell lines, compared to eight
sequence overlaps expected given the number and size distribution of successful reads
from each library (Fig. 23). The total length of non-redundant and mapped RRBS
sequences was 342,556 bp for Dnmt[1kd,3a-/-,3b-/-] and 80,692 bp for wild-type ES cells.
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Figure 20: Genomic location and methylation status of 609 non redundant RRBS sequences from
Dnmt[1kd,3a-/-,3b-/-] ES cells. The blue asterisk indicates reads that were free of methylation. All the reads
that contained methylation have the number of mCpG/CpG displayed. Yellow indicates transcript locations.
The Y chromosome was also hit by RRBS sequences, but is not included in the mapping tool used.
Chapter 3- Results RRBS
75
Figure 21: Genomic location of 148 RRBS sequences from wildtype ES cells. Yellow indicates transcript
locations. The Y chromosome was also hit by RRBS sequences, but is not included in the mapping tool
used.
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Figure 22: RRBS Genome Browser. The main window of the RRBS genome browser is shown.
http://frodo.wi.mit.edu/cgi-bin/jaenisch_rrbs/gbrowse.cgi/mouse_may04
username = jaenisch/ password = rrbs.
The browser works like most common genome browsers, with zoom in/out and different tracks that can be
displayed. In addition, the sequence for each fragment can be viewed. The knockdown and wildtype
fragments display the respective bisulfite converted sequence. The corresponding sequence in the BglII
track provides the uncoverted sequence, which can be used for individual alignments.
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Table 5: Fraction (in per cent) of various types of sequences in the mouse reference
genome, the 500–600 bp BglII reduced representation thereof (RR genome) and RRBS
sequences from Dnmt-deficient and wild-type ES cells.
aRepeat and GC content were taken from (Waterston et al., 2002)
bCpG islands were taken from the mm6 mouse genome assembly on the UCSC genome
browser.
cFraction of genome sequence that falls within gene bounds of non-overlapping
ENSEMBL gene models.
dFraction of RRBS sequences with significant hits to the ENSEMBL gene fraction of the
genome.
eFraction of genomesequence that falls within 5 kb upstream of the transcription start site
of ENSEMBL gene models.
fFraction of RRBS sequences with significant hits to regions 5 kb upstream of
transcription start sites.
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To determine whether these RRBS libraries were generally representative we compared
the GC content, the representation of CpG islands, transcripts, promoter regions and
different classes of repeat elements between the entire mouse genome (Waterston et al.,
2002), the 500-600 bp BglII fraction thereof and the genome sequences hit by the RRBS
clones (Table 5). While reducing the representation introduced a noticeable bias, in
particular a reduction of repeats, bisulfite conversion, PCR amplification, cloning and
sequencing did not. The GC content of loci covered by RRBS sequences ranged from 32
to 63%, indicating satisfactory performance of our protocol over a wide range of GC
content. Likewise, the distribution of the sequenced clones in the genome did not show
conspicuous hot or cold spots (see Figs 20 and 21). Taken together, our data suggest that
RRBS libraries are sufficiently random and representative of the genome fraction used to
make them.
Reducing the complexity by size fractionation of a limit digest with BglII
(recognition site AGATCT) is expected to bias somewhat against GC-rich regions of the
genome. Pooling two single digests with compatible enzymes such as BglII and BamHI
(GGATCC) before the size selection would sample the genome more evenly and increase
the complexity of the RRBS libraries.
Comparison of wild-type and Dnmt-deficient ES cells
The RRBS sequences revealed the methylation status of 66,212 cytosines in
Dnmt[1kd,3a-/-,3b-/-] ES cells (Table 4, bottom half). Only 38 of these were inferred to be
methylated, 35 of them in CpG and three in CpT dinucleotide context. Considering the
non-random distribution of mC among the four dinucleotides, it unlikely that all of them
were caused by incomplete bisulfite conversion or PCR or sequencing errors. Moreover,
the 35 mCpGs are ~1% of all bisulfite-sequenced CpGs, which is close to the 2% mCpG
level determined by NNA (Fig. 19d). By comparison, 90% of CpGs were methylated in
wild type ES cells. We also observed a considerable difference in the level of non-CpG
methylation [(mCpA+mCpT)/C], which was >250-fold reduced in the Dnmt-deficient ES
cells.
In the Dnmt[1kd,3a-/-,3b-/-] RRBS sequences, 25,020 bases were covered 2- or 3-
fold, comprising 4,669 cytosines including 217 CpGs. Overlapping RRBS sequences
agreed for most loci. In two cases, only one sequenced Dnmt[1kd,3a-/-,3b-/-] clone
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displayed a methylcytosine. At another discordant site, the two reads agreed at one
mCpG but disagreed at another.
To address the issue of heterogeneity, we selected ten loci with mCpGs and ten
loci without methylation and designed specific PCR primers to bisulfite re-sequence them
in a targeted fashion. Multiple clones were sequenced for each locus in wild type,
Dnmt[3a-/-,3b-/-] and the Dnmt[1kd,3a-/-,3b-/-] cells. In all but one case, at least one re-
sequenced clone matched the previously determined mCpG pattern precisely, and the
overall level of methylation for each region was similar in all cases (Fig. 24 and data not
shown). Thus, as a rule, a single clone from the RRBS library provides a good indication
of the general methylation pattern at any given site. This is in line with the predominantly
bimodal methylation profiles observed previously (reviewed in Ref. (Bird, 2002)). For
example, >80% of the loci in the HEP survey of the MHC were either hypermethylated or
hypomethylated (Rakyan et al., 2004).
Four representative examples are shown in Fig. 24. For the two loci on
chromosome 4 and 15, respectively, all clones, including the clone from the RRBS
library, indicated complete absence of methylation in Dnmt[1kd,3a-/-,3b-/-] cells. The sister
cell line with normal Dnmt1 levels (see Fig. 18) was also considerably demethylated at
these sites compared to wild-type ES cells. The two other loci maintained more mCpGs
in the methylation-impaired cell lines. The two CpGs on chromosome 17 that were most
consistently methylated in Dnmt[3a-/-,3b-/-] cells showed also residual methylation in the
Figure 24: Targeted bisulfite sequencing of specific loci. Ten loci for which RRBS sequencing indicated
mCpGs in Dnmt-deficient cells and 10 loci that were devoid of methylation were bisulfite re-sequenced
using specific primers in wild-type (top), 3a/b double knockout (middle) and Dnmt[1kd,3a-/-,3b-/-] cells
(bottom). Shown are two examples of each set. Each row represents a single sequenced molecule. Filled
squares are methylated CpGs and empty ones indicate unmethylated sites. The asterisk indicates the original
clone sequenced from the library.
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Dnmt[1kd,3a-/-,3b-/-] cells. One of these two mCpGs was detected in the RRBS clone.
Targeted resequencing detected methylation at the second CpG. This pattern is consistent
with passive random loss of CpG methylation in Dnmt[1kd,3a-/-,3b-/-] cells.
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Chapter 4- Discussion
Much of our current research is focused on understanding the mechanisms that
govern nuclear reprogramming through various approaches including nuclear transfer.
This is ultimately aimed at generating patient-specific uncommitted stem and progenitor
cells that may be useful for cell replacement therapies. The goal of the studies described
here was to establish a set of methods that try to increase the understanding as well as the
efficiency of epigenetic reprogramming. The potential applications of the tools and data
presented here are manifold and will therefore be discussed in a more general way.
Conditional RNA interference
Since the development of gene targeting technologies in ES cells (Thomas and
Capecchi, 1987), the gold standard for the analysis of gene function in mammals has been
the creation of knock-out mice. Improvements to this technology have allowed for a more
refined analysis of gene function at specific developmental stages or in specific tissues.
These refined techniques are based on conditional knock-out strategies that are controlled
by Cre-lox-regulated recombination (Van Dyke and Jacks, 2002). Despite significant
technical improvements over the last decade, however, the creation of loss-of-function
alleles in mice remains time consuming and costly. The recent demonstration that the
RNA pol III-driven expression of shRNAs can be used to functionally silence gene
expression in transgenic mice suggests that RNAi-based technologies might be a
convenient alternative to gene targeting through homologous recombination (Carmell et
al., 2003; Kunath et al., 2003; Rubinson et al., 2003).
A major limitation of current approaches for transgenic RNAi is the inability to
regulate the expression of shRNA. Instead, approaches result in constitutive gene
silencing in all tissues. The lentiviral vectors described here overcome this limitation.
The compact nature of RNA polymerase III promoters (Paule and White, 2000)
prevents the use of a conventional Lox-STOP-lox strategy to achieve Cre-inducible
shRNA expression. Some investigators have recently tried to circumvent this problem by
placing the lox-STOP-lox cassette in the loop region of the shRNA (Fritsch et al., 2004;
Kasim et al., 2004). However, this approach results in the transcription of the residual
loxP site as part of the shRNA, resulting in the synthesis of a longer dsRNA that
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processed less efficiently (Fritsch et al., 2004) and might elicit non-specific, off-target
effects or an IFN response (Stark et al., 1998). By using a mutant lox site that contains a
functional TATA box in its spacer sequence, we were able to obtain Cre-regulated
transcription and efficient processing of a normal-length shRNA.
The potential applications of RNAi-based technology was further extended with
the creation of the lentiviral vector pSicoR, in which constitutive shRNA expression can
be terminated by a Cre-mediated recombination event. As demonstrated for Dnmt1, this
vector can be used to determine the functional consequences of gene reactivation and will
facilitate rescue experiments in vivo. In addition, by mimicking the action of small-
molecule drugs designed to activate the proteins or pathways controlled by human
disease genes (e.g., tumor suppressor genes), this strategy could be used to identify
promising new targets for drug development.
Because preparation of conditional RNAi constructs only requires the cloning of
short synthetic DNA sequences, a large number of conditional knock-down strains can be
generated in parallel by a single investigator. This approach is thus ideally suited for
large-scale projects aimed at the characterization of genetic pathways or the validation of
candidate target genes identified through gene profiling screenings. For example, gene
expression profiling in murine cancer models typically yields numerous genes that
distinguish tumor from normal tissue. Using conventional or conditional knock-out
strategies, it is practical to examine the functional relevance of only a small fraction of
these genes. In contrast, shRNA conditional systems, such as pSico, greatly reduce the
time, cost and effort required to perform such large-scale experiments.
It is important to note that although pSico and pSicoR were used in this work to
control the expression of ‘‘artificial’’ shRNAs, they might also be used to spatially and
temporally regulate the expression of naturally occurring microRNAs -- an approach that
could help unravel the biological functions of this abundant class of small RNAs (Bartel,
2004).
The two lentiviral vectors reported here allow for greater control over gene
inactivation compared with constitutive shRNA expression systems, an advance that
expands the number of potential applications of RNAi-based technologies. The pSicoR
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vector has been successfully used to test a proposed modification of the current nuclear
transfer procedure called altered nuclear transfer.
Altered nuclear transfer
The ethical controversy surrounding nuclear transplantation arises from the
unavoidable destruction of the reconstructed human blastocyst in order to obtain
embryonic stem cells useful for biomedical research and therapy. The available evidence
suggests that after nuclear transfer, the reconstructed embryos lack the potential to
develop into normal human beings with any acceptable or practical efficiency (Jaenisch,
2004). Despite the incompatibility of this approach with normal human development, the
utility and promise of nuclear transfer lies in the development of embryonic stem cells
that have the same biological and molecular characteristics and the same therapeutic
potential as those derived from fertilized embryos (Brambrink et al., 2006; Jaenisch,
2004). Altered nuclear transfer further cripples the already compromised blastocyst and
eliminates the potential for the blastocyst to implant into the uterus and establish the
fetal-maternal connection (Hurlbut, 2005). The genetic manipulations of the somatic
donor cells that are required to generate this inherently abnormal blastocyst are simple
and straightforward. Our data indicate that the removal of the Cdx2 gene from somatic
cells prior to nuclear transfer results in the formation of a blastocyst that lacks the
functional cells of the trophectoderm lineage. This finding is consistent with previous
results with embryos from mutant animals (Strumpf et al., 2005). Because the Cdx2 gene
is expressed prior to the blastocyst stage (Strumpf et al., 2005), Cdx2-deficient clones are
abnormal at the pre-blastocyst stages, before an overtly abnormal phenotype becomes
apparent. By reversing the Cdx2 deficiency we demonstrate that fully competent ES cells
can be derived from the inherently abnormal product of nuclear transfer using Cdx2-
deficient donor cells.
If ANT was ever contemplated as an approach for the generation of human ES
cells by nuclear transfer, the following issues need to be considered. First, although
CDX2 is expressed in the trophectoderm of human blastocysts (Adjaye et al., 2005) and
derivatives of hES cells (Hyslop et al., 2005), its expression pattern in the human fetus
has not been determined. As such, it is unknown whether the effect of CDX2 on
placentation will be the same in humans as in mice. Because the effect of gene inhibition
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on human placentation cannot be tested, surrogate assays such as in vitro differentiation
of hES cells are required to assess the effect of CDX2 deficiency on human trophoblast
development.  In addition, with the use of retroviral vectors for gene transduction (Pfeifer
et al., 2002) comes the risk of insertional mutagenesis and thus the activation of
oncogenes that can cause leukemia (Hacein-Bey-Abina et al., 2003). However, this
probably does not represent a serious problem in ANT because, in contrast to the gene
therapy trials using retroviral infection of bone marrow cells, viral integration into the
fibroblasts does not lead to a proliferative advantage and selective outgrowth of infected
cells due to an activated oncogene. Finally, since all nuclear transfer-derived ES cells are
clonal, simple DNA analysis would indicate whether proviral integration occurred in the
vicinity of an oncogene.
The results reported in this study provide proof of principle that inhibition of
genes important for trophoblast function can prevent placentation without interfering with
ES cell potency, and may thus provide a scientific way to side-step the ongoing debate
surrounding the nuclear transfer technology. However, because the Cdx2-deficient
embryo is not obviously abnormal before the onset of Cdx2 expression, this approach
may not solve the ethical dilemma. Moreover, research with primate or human cells will
be required to assess whether Cdx2 is an optimal target for human application. Finally,
we wish to emphasize that ANT is simply a modification and not an alternative to nuclear
transfer. As the approach requires additional manipulation of the donor cells, it is likely
to complicate the logistics of production and safety assessment of therapeutic patient-
specific ES cell lines.
Some critics have raised doubts about whether an essential role of CDX2 in
human placentation could ever be established, thus making it impossible to assess the
potential effectiveness of the ANT approach in humans (Solter, 2005). While CDX2’s
role in human placentation cannot be studied in mutant embryos, a simple in vitro assay
could be developed. For example, human ANT blastocysts could be explanted in culture
to verify whether CDX2 deficiency prevents the generation of trophoblast cells – the cells
that generate the placental lineage - as it does in the mouse. Although such surrogate
assays cannot provide 100% certainty regarding the effect of CDX2 deficiency on human
placentation, a positive in vitro result would provide sufficient confidence that inhibition
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of the CDX2 gene would abrogate the reproductive cloning potential of ANT-derived
human blastocysts. It has also been argued that because of the dependence of siRNA
expression on genomic integration, numerous human ANT embryos would have to be
tested to assure sufficient CDX2 inhibition. However, linking siRNA with GFP
expression provides a simple way to isolate donor cells that contain a high level of CDX2
siRNA prior to nuclear transfer. Finally, although ANT will probably not persuade
everyone who opposes nuclear cloning, and attempts to find technological solutions to
contentious ethical issues may represent a diversion of the scientific process (Melton et
al., 2004), we also find merit in another argument. Our work is supported by public
funds. As a result, it could be argued that we have an obligation to take the public debate
on scientific and ethical issues seriously and to contribute to possible solutions. As long
as the experiments performed in pursuit of this goal are scientifically sound, it is a moot
point whether such efforts would lead to a resolution of the controversy.
As described in Chapter 1, a great deal of current research is focused on the de-
differentiation and/or reprogramming of somatic cells with the ultimate goal of
generating less differentiated cells that will be useful for patient therapy. The cloning of
fully differentiated cells has demonstrated that no genetic information is lost during
development and that nuclear totipotency is retained. This suggested that epigenetic
mechanisms of gene regulation and differentiation are responsible for keeping somatic
cells in their differentiated state. In order to better define the epigenome of different cell
types, we have developed an approach for large-scale high resolution DNA methylation
analysis.
Genome-wide high resolution DNA methylation analysis
In this work, we explored the feasibility of large-scale shotgun bisulfite
sequencing for genome-wide analysis of DNA methylation. We have shown that bisulfite
sequencing libraries can be constructed that are largely unbiased and representative of the
genome. These libraries display few false-positive methylcytosines caused by incomplete
cytosine to uracil conversion or PCR and sequencing errors.
Insert sizes of the libraries were kept very small (500-600 bp) for two reasons.
First, the bisulfite reaction requires relatively high temperatures (50-60°C) and a low pH
(pH5) -- conditions that are known to cause depurination and strand breakage. In
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addition, smaller molecules are less prone to damage and require fewer PCR cycles to
recover intact molecules suitable for cloning compared with larger ones, thereby
minimizing the risk of a skewed representation. Finally, larger-insert clones would
require sequencing of both strands, and C-poor strands have proven difficult to sequence
in our hands.
We used limit digestion with BglII and size fractionation to reduce the complexity
of the DNA. The resulting RRBS libraries cover a small but reproducible fraction of the
genome and are therefore suitable for large-scale comparative methylation studies across
different strains, tissues or cell types. Based on the overall success rate (72%) and insert-
size distributions encountered during this pilot study (Fig. 23), we expect that for a pair-
wise comparison, sequencing 100 x 384 RRBS clones from each DNA sample will
produce 4.0 Mb of high-quality, overlapping bisulfite sequence with 2- to 3-fold coverage
in each library of fragments within 1 SD of the mean size. Assuming that improvements
in sequencing of C-poor strands (85% success rate) and better libraries with congruent
insert-size distributions can be made, the same sequencing effort would yield ~5.8 Mb of
pair-wise comparative sequence which, of course, is still only a tiny fraction of the
genome.
At this level of genome coverage, differential methylation at most individual sites
in the genome, including many functionally important ones, is likely to escape detection.
However, we expect the coverage to be sufficient to generate methylation variable
position markers for future bisulfite SNP “epigenotyping” (Murrell et al., 2005). A
genome-wide set of comparative bisulfite sequences may prove useful to train computer
algorithms for predicting methylation patterns. RRBS sequencing may be sufficient to
detect genomic imprints (or the loss thereof), tissue-specific regulated methylation
domains or long-range methylation gradients along a chromosome. We also envision
RRBS applications in epigenetic cancer profiling and bio-marker discovery.
Despite the essential role of the known DNA methyltransferases in mouse
development (Li et al., 1992; Okano et al., 1999), DNA methylation and the enzymes
responsible for its establishment and maintenance appear to be largely dispensable in
undifferentiated ES cells. Dnmt1-deficient ES cells retain approximately 20% CpG
methylation, likely due to continuous de novo methylation by Dnmt3a and Dnmt3b.
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Although early passage Dnmt3a/b double mutant ES cells show almost wild-type levels
of CpG methylation (Chen et al., 2003; Jackson et al., 2004), they progressively lose
methylation with <1% remaining after 75 passages (Jackson et al., 2004). This gradual
loss may reflect the infidelity of the maintenance enzyme Dnmt1.
Our data showed that ES cells that lack the DNA methyltransferases Dnmt3a and
3b and have greatly reduced levels of Dnmt1 were viable with 1-2% CpG methylation
remaining after only six passages. The extremely low rate of false-positive
methylcytosines allowed us to identify and inspect some of the rare sites that retained
methylation. There were no obvious hotspots for residual mCpGs in the genome (Figures
20 and 21). Also, there was no correlation between the numbers of CpGs and the residual
methylation at a given site. The distance to CpG islands or to known genes also appeared
to be random and none of the loci was notably conserved across species. Finally, no
specific motif was detected upstream or downstream of the residual mCpG dinucleotides
(data not shown). Thus these findings provide no evidence of specific maintenance of
residual mCpG by an unidentified DNA methyltransferase. Rather, Dnmt[1kd,3a-/-,3b-/-]
cells seem to lose residual CpG methylation in a random fashion over time.
Only 3 of the 25,505 sequenced CpT dinucleotides were inferred to be methylated
in Dnmt-deficient cells, and no methylated CpA was detected. By comparison, wild-type
cells showed 0.7% CpT and 2.4% CpA methylation in agreement with previous
observations (Dodge et al., 2002; Ramsahoye et al., 2000). Previous experiments have
also shown that the presence of Dnmt1 is not required for non-CpG methylation
(Ramsahoye et al., 2000). In contrast, non-CpG methylation becomes almost undetectable
in ES cells lacking Dnmt3a and Dnmt3b (Dodge et al., 2002). Both global nearest
neighbor data and our bisulfite-sequencing data therefore suggest that the de novo DNA
methyltransferases 3a and/or 3b are responsible for asymmetric CpA and CpT
methylation in murine ES cells.
In this pilot study we have employed a combination of RNAi-induced knock-
down and complete knockout of DNA methyltransferases to generate murine ES cells
that were almost completely devoid of DNA methylation. These cells had only 1-2%
residual CpG methylation left after a few passages, and non-CpG methylation was over
250-fold reduced compared to wild-type ES cells.
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Unamplified, nearly methylation-free genomic DNA is an ideal substrate to
optimize and test conditions for genome-wide bisulfite conversion, PCR amplification
and library construction for future genomic shotgun bisulfite sequencing of mammalian
genomes. We have shown that essentially complete bisulfite conversion can be achieved
without undue adverse effects on library complexity and sequence representation.
Perspectives
RNA interference has become one of the predominant tools to assess gene
function across all species. In the near future, it is likely that a catalog of functional
siRNAs will be available for every known gene in most organisms. And further studies
comparing the mechanisms of endogenous miRNAs and synthetic siRNA should increase
the efficiency of rational RNAi design. The discovery and optimization of RNAi will
undoubtedly lead to advances in medical treatment, either directly as therapy or by
revealing new gene targets for therapy.
In the 50 years since Briggs and King first reported the nuclear transfer technique,
NT has become a powerful research tool that holds great promise for therapy in the years
to come. The prospect of deriving customized ES cells has significant implications for
medical therapy, and, more immediately, for the use of patient-derived ES cells as disease
models. For instance, stem cells derived from a patient that suffers from Parkinson’s
disease would provide limitless material to study the physiology of the affected cells.
Typically, by the time Parkinson’s disease is diagnosed, most of the cells have been lost.
Stem cells derived from patients could be differentiated into neurons in vitro and then
used for mechanistic studies. These cells might also provide a means of screening
candidate drugs and compounds with the potential to counter neurodegeneration. The
long-term goal, however, remains patient-tailored cell replacement therapy. This goal
will require longer-term clinical trials and the resolution of numerous safety issues before
such a therapy could be implemented in patients.
One of the next steps in studying stem cell biology will be to decipher the
epigenome of stem cells and compare it to differentiated cells. As discussed, large-scale
random bisulfite sequencing complements existing directed bisulfite sequencing
strategies, which are well suited to analyze a limited number of gene promoters and
regulatory sequence elements in a large number of samples. One advantage of sequencing
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clone libraries in a random fashion is that no target-specific PCR or sequencing primers
are needed. Once the library is made, the method is amenable to automation and is
scaleable. Since the bisulfite reads are not assembled but merely aligned to the reference
genome sequence, we expect this method to work well in combination with highly
parallel sequencing technologies that produce single reads of approximately 100 bases in
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The goal of the studies described here was to establish a set of methods aimed at
ultimately enhancing the efficiency of epigenetic reprogramming. The use of RNA
interference (RNAi) for studying and influencing gene function has become an essential
part of biology. In this work, we have described two lentivirus-based vectors used for
conditional, Cre-lox regulated RNAi in cells and in mice. One vector triggers Cre-
dependent activation (pSico) and the other Cre-dependent termination (pSicoR) of
shRNA expression. These vectors were used to conditionally and reversibly knock-down
p53, Npm, and Dnmt1 expression in ES cells and in MEFs. As a proof of principle, pSico
was used to generate conditional and tissue-specific knock-down mice. As outlined in
Chapter 1 conditional depletion of various gene products by RNAi will provide better
understanding of the factors involved in epigenetic reprogramming. This knowledge
should ultimately lead to enhancing the efficiency of successful reprogramming. The
pSicoR system was applied in later experiments to temporally suppress Cdx2 function in
donor nuclei prior to nuclear transfer, a modification of the current procedure, termed
altered nuclear transfer (ANT). Finally, deciphering the epigenome of different cell types
is critical for understanding the regulation of both normal development and disease states.
In the last part of this work we have devised a new strategy that permits high-resolution
comparative DNA methylation analysis. The system was tested in ES cells depleted of
DNA methylation by elimination of the DNA methyltransferases Dnmt1, Dnmt3a and 3b.





Der Transfer eines differenzierten Zellkerns in eine entkernte Eizelle
(Kerntransfer) ist einer von mehreren experimentellen Ansätzen um die
Reprogrammierung von differenzierten Zellen zu erreichen. Unter Reprogrammierung
vesteht man grundsätzlich die Erweiterung des Entwicklungspotentials einer
differenzierten Zelle. Eines der Hauptziele von Kerntransfer-Experimenten ist es
undifferenzierte Stamm- oder Vorläuferzellen hervorzubringen, welche für
Zellersatztherapien genutzt werden können. Der Hauptvorteil von humanen Kerntransfer-
Stammzellen liegt darin, dass sie patientenspezifisch sind und dadurch nicht vom
Immunsystem als fremd erkannt würden.
Einer der Schwerpunkte unserer gegenwärtigen Forschung ist es, ein besseres
Verständnis der Mechanismen und Faktoren, die in der Kernreprogrammierung involviert
sind, zu gewinnen. Die Tatsache, dass vollständig differenzierte Zellen mittels
Kerntransfer reprogrammiert werden können, zeigt, das im Verlauf der Entwicklung
keine genetische Information verloren geht, d.h. differenzierte Zellkerne enthalten
sämtliche Informationen um einen kompletten Organismus hervorzubringen. Diese
Ergebnisse deuten darauf hin, dass die Regulierung der Differenzierung über
epigenetische Mechanismen gesteuert wird. Epigenetische Modifikationen sind stabile
Veränderungen der DNA oder des Chromatins, die jedoch die primäre DNA Sequenz
nicht verändern. Das Ziel meiner Untersuchen ist es, Methoden und ein besseres
Verständnis der involvierten Faktoren zu entwickeln, um den Vorgang der
Reprogrammierung verbessern zu können.
Im ersten Teil meiner Arbeit beschreibe ich ein neues System zur Cre-Lox
regulierbaren Gen Inhibierung durch RNA Interferenz. Die Effektivität und
Funktionalität des Systems wurde für mehrere Gene in vitro und in vivo gezeigt. Neben
vielen anderen nützlichen Anwendungen, wie konditionelle Regulierung von essentiellen
Genen in vivo, was hier für das Tumorsuppressorgen p53 gezeigt wurde, erlaubt das
System transiente Blockierung von Faktoren, die epigenetische Modifikationen
regulieren, wie z.B. DNA Methyltransferase 1 (Dnmt1). Es konnte bereits gezeigt
werden, dass eine Reduzierung der genomischen DNA Methylierung einen positiven
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Einfluss auf die Effizienz des Reprogrammierens durch Kerntransfer hat. Allerdings
ergeben sich aus der daraus bedingten Hypomethylierung der DNA auch negative
Konsequenzen, wie z.B. vermehrtes Auftreten von Tumoren. Diese negativen
Auswirkungen lassen sich durch zeitlich beschränkte Inhibierung des Enzyms
vermindern, da nach dem Entfernen des RNAi Systems das endogene Gen wieder aktiv
ist.
Im zweiten Teil beschreibe ich eine Modifikation der normalen Kerntransfer
Technik. Dabei wird eine Gen, mittels des oben beschriebenen RNAi Systems blockiert,
was unerlässlich ist für die Differenzierung in Trophectoderm, welches später die
Plazenta formt. Dadurch wird kein funktioneller Embryo erzeugt, aber es lassen sich
trotzdem Stammzellen gewinnen. Diese Experimente stellen eine wissenschaftliche Basis
für die Diskussion über die Gewinnung von Stammzellen dar, und erlauben ausserdem
weitere Analysen von essentiellen Faktoren die für die extraembryonalen Gewebe
notwendig sind. Dies ist wichtig, da viele essentielle Gene im geklonten Embryo selbst,
aber auch in seinen extraembryonalen Teilen, nicht korrekt reaktiviert werden.
Obwohl die DNA Sequenz zwischen Stammzellen und differenzierten Zellen
identisch ist, sind sie epigentisch verschiedenen. Um diese Unterschiede im gesamten
Genom besser untersuchen zu können, haben wir eine Methode entwickelt, die es erlaubt
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